{
  "file_name": "CUAD_v1/full_contract_pdf\\Part_I\\Co_Branding\\MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.pdf",
  "annotations": [
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Document Name_0",
      "question": "Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract",
      "answer_text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "MusclePharm Corporation",
      "page_number": 0,
      "words": [
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_21",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Fitness Publications, Inc.",
      "page_number": 21,
      "words": [
        {
          "text": "Fitness Publications, Inc.",
          "bbox": [
            457.0,
            2469.0,
            919.0,
            2505.0
          ],
          "confidence": 0.9771222472190857
        }
      ],
      "nearby_headers": [
        {
          "text": "19. Modification of Agreement:.",
          "page": 21,
          "bbox": [
            448.0,
            424.0,
            1049.0,
            470.0
          ]
        },
        {
          "text": "20. Notice:",
          "page": 21,
          "bbox": [
            444.0,
            648.0,
            651.0,
            697.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Fitness",
      "page_number": 0,
      "words": [
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Endorser",
      "page_number": 0,
      "words": [
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Arnold Schwarzenegger",
      "page_number": 0,
      "words": [
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "collectively, Lender, Endorser, and Fitness are referred to as the \"AS Parties\"",
      "page_number": 0,
      "words": [
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_21",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Marine MP, LLC",
      "page_number": 21,
      "words": [
        {
          "text": "Marine MP, LLC",
          "bbox": [
            457.0,
            2187.0,
            759.0,
            2224.0
          ],
          "confidence": 0.9994738698005676
        }
      ],
      "nearby_headers": [
        {
          "text": "19. Modification of Agreement:.",
          "page": 21,
          "bbox": [
            448.0,
            424.0,
            1049.0,
            470.0
          ]
        },
        {
          "text": "20. Notice:",
          "page": 21,
          "bbox": [
            444.0,
            648.0,
            651.0,
            697.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Lender",
      "page_number": 0,
      "words": [
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "collectively, \"MusclePharm\" or the \"Company\"",
      "page_number": 0,
      "words": [
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Agreement Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract",
      "answer_text": "July 26, 2013",
      "page_number": 0,
      "words": [
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Effective Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective ",
      "answer_text": "July 26, 2013",
      "page_number": 0,
      "words": [
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Expiration Date_1",
      "question": "Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract's initial term expire?",
      "answer_text": "The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        }
      ],
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Expiration Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract's initial term expire?",
      "answer_text": "This Agreement shall have an Initial Term of three (3) years.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Renewal Term_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "If this Agreement is renewed for the First Additional Term, then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice on July 22, 2019.",
      "page_number": 1,
      "words": [
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        }
      ],
      "multi_page": true,
      "part_of": 1,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Renewal Term_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "If this Agreement is renewed for the Second Additional Term, then the Second Additional Term shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022.",
      "page_number": 1,
      "words": [
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        }
      ],
      "multi_page": true,
      "part_of": 1,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Renewal Term_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement).",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Renewal Term_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement).",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Renewal Term_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term\") on the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C\" Section (3) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional Term (subject to Section 12(b) of this Agreement).",
      "page_number": 1,
      "words": [
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        }
      ],
      "multi_page": true,
      "part_of": 1,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Governing Law_6_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country's law governs the interpretation of the contract?",
      "answer_text": "This Agreement has been executed and delivered in Los Angeles County in the State of California, and its interpretation, validity and performance shall be construed and enforced in accordance with the laws of the State of California.",
      "page_number": 6,
      "words": [
        {
          "text": "(c) Editorial Uses. Endorser also grants to MusclePharm and consents to MusclePharm's editorial use world-wide of Endorser's Name",
          "bbox": [
            466.0,
            422.0,
            3027.0,
            468.0
          ],
          "confidence": 0.9951181411743164
        },
        {
          "text": "and Appearance in MusclePharm published materials approved by Endorser. For purposes of this Agreement, MusclePharm's editorial use of",
          "bbox": [
            277.0,
            479.0,
            3032.0,
            524.0
          ],
          "confidence": 0.9957801699638367
        },
        {
          "text": "Endorser's Name and Appearance shall mean a use that does not directly promote, advertise or endorse MusclePharm's business, its Products or",
          "bbox": [
            279.0,
            539.0,
            3030.0,
            581.0
          ],
          "confidence": 0.9949312210083008
        },
        {
          "text": "Licensed Products. Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8",
          "bbox": [
            279.0,
            594.0,
            3029.0,
            638.0
          ],
          "confidence": 0.9923977255821228
        },
        {
          "text": "of this Agreement (including, without limitation, with respect to any renewal Term, if any).",
          "bbox": [
            277.0,
            647.0,
            1943.0,
            694.0
          ],
          "confidence": 0.9934976696968079
        },
        {
          "text": "(d) Discretion to Utilize. Except as otherwise provided in this Agreement, MusclePharm may in its sole discretion exercise some or all of the",
          "bbox": [
            448.0,
            762.0,
            3025.0,
            802.0
          ],
          "confidence": 0.9890238642692566
        },
        {
          "text": "rights granted by Endorser in this Agreement, but MusclePharm shall have no obligation to exercise or use the rights Endorser has granted. If",
          "bbox": [
            275.0,
            815.0,
            3032.0,
            863.0
          ],
          "confidence": 0.9906589984893799
        },
        {
          "text": "MusclePharm elects to not exercise or use all the rights granted by Endorser, MusclePharm's election shall not be interpreted or construed as a",
          "bbox": [
            277.0,
            875.0,
            3029.0,
            917.0
          ],
          "confidence": 0.9925275444984436
        },
        {
          "text": "waiver or release of such rights. MusclePharm shall have the rights to use Endorser's Name and Appearance Rights and the Right to Publicize",
          "bbox": [
            277.0,
            932.0,
            3027.0,
            974.0
          ],
          "confidence": 0.9982631206512451
        },
        {
          "text": "Endorser's Name and Appearance, as provided in this Agreement, unless Endorser and MusclePharm enter into a separate written agreement in",
          "bbox": [
            275.0,
            985.0,
            3029.0,
            1031.0
          ],
          "confidence": 0.9940312504768372
        },
        {
          "text": "which MusclePharm waives or releases some or all of the rights Endorser has granted in this Agreement..",
          "bbox": [
            277.0,
            1043.0,
            2217.0,
            1084.0
          ],
          "confidence": 0.9947088956832886
        },
        {
          "text": "(e) Representations and Warranties. Endorser expressly represents and warrants that he is not subject to any restriction or limitation by.",
          "bbox": [
            448.0,
            1155.0,
            3025.0,
            1199.0
          ],
          "confidence": 0.9884305000305176
        },
        {
          "text": "way of employment or contractual obligation that may impair or limit the right of publicity granted herein by Endorser, and that Endorser has the",
          "bbox": [
            279.0,
            1210.0,
            3027.0,
            1255.0
          ],
          "confidence": 0.9938377737998962
        },
        {
          "text": "express approval of his employer to make the promises and commitments set forth herein..",
          "bbox": [
            279.0,
            1266.0,
            1938.0,
            1312.0
          ],
          "confidence": 0.9902227520942688
        },
        {
          "text": "6A. News Releases and Public Announcements:.",
          "bbox": [
            446.0,
            1378.0,
            1358.0,
            1420.0
          ],
          "confidence": 0.987896203994751
        },
        {
          "text": "Neither party may, without the other party's prior written consent, make any news release or public announcement of the existence or.",
          "bbox": [
            444.0,
            1493.0,
            3031.0,
            1540.0
          ],
          "confidence": 0.9955464005470276
        },
        {
          "text": "value of this Agreement or its terms and conditions, or in any other manner advertise or publish its value, or its terms and conditions and neither",
          "bbox": [
            281.0,
            1551.0,
            3027.0,
            1592.0
          ],
          "confidence": 0.9950768947601318
        },
        {
          "text": "party shall issue any press release or other public announcement which includes the name of the other party without such party's prior written",
          "bbox": [
            277.0,
            1606.0,
            3027.0,
            1652.0
          ],
          "confidence": 0.9919009208679199
        },
        {
          "text": "consent, such consent not to be unreasonably withheld or delayed. The parties hereby agree that within four (4) business days after the execution",
          "bbox": [
            279.0,
            1665.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9868282079696655
        },
        {
          "text": "and delivery of this Agreement and within four (4) business days after the launch of the Licensed Products, the parties hereto shall issue a joint",
          "bbox": [
            279.0,
            1723.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.996801495552063
        },
        {
          "text": "press release in form and substance mutually agreeable to the parties hereto. Notwithstanding the foregoing, a party may make any filing of this",
          "bbox": [
            277.0,
            1778.0,
            3027.0,
            1820.0
          ],
          "confidence": 0.9944470524787903
        },
        {
          "text": "Agreement or description of this Agreement in a current report on Form 8-K or similar requisite filing with the Securities and Exchange Commission",
          "bbox": [
            283.0,
            1836.0,
            3027.0,
            1873.0
          ],
          "confidence": 0.9947243332862854
        },
        {
          "text": "that it believes in good faith and upon a reasonable basis is required by applicable law or any listing or trading agreement concerning its publicly",
          "bbox": [
            275.0,
            1886.0,
            3025.0,
            1933.0
          ],
          "confidence": 0.991354763507843
        },
        {
          "text": "traded securities.",
          "bbox": [
            277.0,
            1944.0,
            595.0,
            1985.0
          ],
          "confidence": 0.9995260238647461
        },
        {
          "text": "6B. Sample Products for Endorser's Use:.",
          "bbox": [
            450.0,
            2058.0,
            1222.0,
            2100.0
          ],
          "confidence": 0.9822939038276672
        },
        {
          "text": "MusclePharm shall provide a reasonable supply of Products, Licensed Products, and Promotional Products for Endorser's personal use",
          "bbox": [
            446.0,
            2171.0,
            3023.0,
            2213.0
          ],
          "confidence": 0.9853043556213379
        },
        {
          "text": "and endorsement as contemplated by this Agreement..",
          "bbox": [
            277.0,
            2226.0,
            1283.0,
            2273.0
          ],
          "confidence": 0.9844739437103271
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9968801140785217
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Governing Law_7_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country's law governs the interpretation of the contract?",
      "answer_text": "This Agreement has been executed and delivered in Los Angeles County in the State of California, and its interpretation, validity and performance shall be construed and enforced in accordance with the laws of the State of California.",
      "page_number": 7,
      "words": [
        {
          "text": "7. Compensation:",
          "bbox": [
            446.0,
            422.0,
            781.0,
            470.0
          ],
          "confidence": 0.9963328838348389
        },
        {
          "text": "(a) Cash:",
          "bbox": [
            448.0,
            539.0,
            613.0,
            585.0
          ],
          "confidence": 0.993758499622345
        },
        {
          "text": "()",
          "bbox": [
            613.0,
            652.0,
            656.0,
            698.0
          ],
          "confidence": 0.7052817344665527
        },
        {
          "text": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the",
          "bbox": [
            785.0,
            656.0,
            3023.0,
            693.0
          ],
          "confidence": 0.9900665879249573
        },
        {
          "text": "\"Royalty') of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution",
          "bbox": [
            781.0,
            707.0,
            3027.0,
            753.0
          ],
          "confidence": 0.9963505864143372
        },
        {
          "text": "Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any",
          "bbox": [
            783.0,
            762.0,
            3025.0,
            810.0
          ],
          "confidence": 0.9946409463882446
        },
        {
          "text": "Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i)",
          "bbox": [
            779.0,
            819.0,
            3025.0,
            864.0
          ],
          "confidence": 0.9930943846702576
        },
        {
          "text": "above. For purposes of this Agreement, \"Net Sales\" shall mean MusclePharm's gross sales (the gross invoice amount",
          "bbox": [
            783.0,
            879.0,
            3030.0,
            921.0
          ],
          "confidence": 0.99349445104599
        },
        {
          "text": "billed customers) of the Licensed Products, less discounts and allowances actually shown on the invoice (except cash",
          "bbox": [
            783.0,
            934.0,
            3025.0,
            974.0
          ],
          "confidence": 0.9931140542030334
        },
        {
          "text": "discounts, transportation costs and commissions not deductible in the calculation of Royalty) and less any bona fide",
          "bbox": [
            783.0,
            990.0,
            3029.0,
            1032.0
          ],
          "confidence": 0.9966821074485779
        },
        {
          "text": "returns (net of all returns actually made or allowed as supported by credit memoranda actually issued to the customers",
          "bbox": [
            781.0,
            1047.0,
            3029.0,
            1087.0
          ],
          "confidence": 0.9979963898658752
        },
        {
          "text": "reporting cycle. No other costs incurred in the manufacturing, selling, advertising, and distribution of the Licensed",
          "bbox": [
            781.0,
            1157.0,
            3029.0,
            1201.0
          ],
          "confidence": 0.9936442375183105
        },
        {
          "text": "Products shall be deducted nor shall any deduction be allowed for any uncollectible accounts, allowances or bad debt.",
          "bbox": [
            781.0,
            1212.0,
            2989.0,
            1257.0
          ],
          "confidence": 0.9939249753952026
        },
        {
          "text": "(ii)",
          "bbox": [
            613.0,
            1325.0,
            669.0,
            1372.0
          ],
          "confidence": 0.8305168747901917
        },
        {
          "text": "A Royalty obligation shall accrue upon the sale of the Licensed Products regardless of the time of collection by",
          "bbox": [
            783.0,
            1327.0,
            3027.0,
            1369.0
          ],
          "confidence": 0.9974666237831116
        },
        {
          "text": "MusclePharm. For purposes of this Agreement, Licensed Products shall be considered \"sold\" upon the date when such",
          "bbox": [
            783.0,
            1383.0,
            3029.0,
            1427.0
          ],
          "confidence": 0.9927148818969727
        },
        {
          "text": "Licensed Products are billed, invoiced, shipped, or paid for, whichever event occurs first..",
          "bbox": [
            779.0,
            1436.0,
            2434.0,
            1482.0
          ],
          "confidence": 0.9904100298881531
        },
        {
          "text": "(iii)",
          "bbox": [
            611.0,
            1548.0,
            678.0,
            1599.0
          ],
          "confidence": 0.9001733064651489
        },
        {
          "text": "If MusclePharm sells any Licensed Products to any party affiliated with MusclePharm, or in any way directly or",
          "bbox": [
            778.0,
            1546.0,
            3029.0,
            1597.0
          ],
          "confidence": 0.9954826831817627
        },
        {
          "text": "indirectly related to or under the common control with MusclePharm, at a price less than the regular price charged to",
          "bbox": [
            779.0,
            1606.0,
            3025.0,
            1650.0
          ],
          "confidence": 0.9837138056755066
        },
        {
          "text": "other parties, the Royalty payable to Lender shall be computed on the basis of the regular price charged to other parties.",
          "bbox": [
            783.0,
            1665.0,
            3018.0,
            1707.0
          ],
          "confidence": 0.9989277124404907
        },
        {
          "text": "(iv)",
          "bbox": [
            613.0,
            1774.0,
            683.0,
            1822.0
          ],
          "confidence": 0.9993475675582886
        },
        {
          "text": "All payments due hereunder shall be made in United States currency drawn on a United States bank, unless otherwise",
          "bbox": [
            787.0,
            1776.0,
            3027.0,
            1818.0
          ],
          "confidence": 0.9947237372398376
        },
        {
          "text": "specified between the parties.",
          "bbox": [
            781.0,
            1831.0,
            1336.0,
            1877.0
          ],
          "confidence": 0.9849197268486023
        },
        {
          "text": "v)",
          "bbox": [
            620.0,
            1953.0,
            665.0,
            1983.0
          ],
          "confidence": 0.7803908586502075
        },
        {
          "text": "During the Term and during the sell-off period, MusclePharm shall make royalty payments in U.S. dollars for the",
          "bbox": [
            783.0,
            1944.0,
            3027.0,
            1986.0
          ],
          "confidence": 0.999644935131073
        },
        {
          "text": "respective quarters ending on the last day of September, December, March and June (each, a \"Royalty Period\") within",
          "bbox": [
            779.0,
            1999.0,
            3027.0,
            2043.0
          ],
          "confidence": 0.9929400682449341
        },
        {
          "text": "showing the nature and source of such royalties, including (i) the number of units of Licensed Products sold (by",
          "bbox": [
            781.0,
            2111.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9922689199447632
        },
        {
          "text": "country and customer); (ii) the total number of units returned for which credit was given and the total dollar amount of",
          "bbox": [
            783.0,
            2169.0,
            3034.0,
            2211.0
          ],
          "confidence": 0.9959548711776733
        },
        {
          "text": "such credits, and (iii) the total gross sales and the total royalties due with respect to such gross sales, and each itemized",
          "bbox": [
            783.0,
            2226.0,
            3029.0,
            2268.0
          ],
          "confidence": 0.9922652244567871
        },
        {
          "text": "statement shall be certified by a duly authorized officer of MusclePharm. Such statements shall be in the form attached",
          "bbox": [
            783.0,
            2284.0,
            3027.0,
            2321.0
          ],
          "confidence": 0.9973651766777039
        },
        {
          "text": "hereto as Exhibit \"B\" and furnished to Lender whether or not any Licensed Products were sold during the Royalty",
          "bbox": [
            779.0,
            2335.0,
            3023.0,
            2381.0
          ],
          "confidence": 0.9932433366775513
        },
        {
          "text": "Period.",
          "bbox": [
            779.0,
            2392.0,
            913.0,
            2432.0
          ],
          "confidence": 0.9999346137046814
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9976791143417358
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "7. Compensation:",
          "page": 7,
          "bbox": [
            446.0,
            422.0,
            781.0,
            470.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Non-Compete_0",
      "question": "Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector? ",
      "answer_text": "Products. Any failure of Endorser to disclose such conflicting interests, or any breach of this Section, shall be deemed a material breach of the Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Non-Compete_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector? ",
      "answer_text": "Endorser's duty not to compete with the business of MusclePharm shall continue for a period of one year following the expiration or termination of this Agreement. Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Non-Compete_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector? ",
      "answer_text": "Endorser's duty not to compete with the business of MusclePharm shall continue for a period of one year following the expiration or termination of this Agreement. Endorser's non-competition obligation shall not be required in the event of a material breach of this Agreement by MusclePharm.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Non-Compete_0",
      "question": "Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector? ",
      "answer_text": "Endorser shall not use or provide endorsements or testimonials for products that compete with MusclePharm Products or the Licensed Products.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Non-Compete_1",
      "question": "Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector? ",
      "answer_text": "Endorser's duty not to compete with the business of MusclePharm shall continue for a period of one year following the expiration or termination of this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Exclusivity_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing  commitment with the counterparty? This includes a commitment to procure all “requirements” from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on  collaborating or working with other parties), whether during the contract or  after the contract ends (or both).",
      "answer_text": "During the term of this Agreement, or any extensions of this Agreement, Endorser and the Lender hereby agree and warrant that it will not enter into any other endorsement agreement for the use of Endorser's name, image and/or likeness for advertising, marketing and/or endorsement of any other dietary supplements during the Term of this Agreemen",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Exclusivity_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing  commitment with the counterparty? This includes a commitment to procure all “requirements” from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on  collaborating or working with other parties), whether during the contract or  after the contract ends (or both).",
      "answer_text": "During the term of this Agreement, or any extensions of this Agreement, Endorser and the Lender hereby agree and warrant that it will not enter into any other endorsement agreement for the use of Endorser's name, image and/or likeness for advertising, marketing and/or endorsement of any other dietary supplements during the Term of this Agreemen",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Competitive Restriction Exception_3_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "Notwithstanding the foregoing, the following will not be a breach of this Agreement: (i) Endorser's performance of services or appearing in the news or informational portion of any radio, TV or film or entertainment program regardless of products or services therein or sponsorship thereof; (ii) Endorser's participation in movies or TV programs as well as merchandising, commercial tie-ins and/or product placements utilizing Endorser, or (iii) Endorser's performance of services, appearance or use of his name, likeness in connection with charitable events, sports events, organizations, regardless of usage of products or services and/or sponsorship thereof.",
      "page_number": 3,
      "words": [
        {
          "text": "4. Appearances, Advertising and Promotional Activities:.",
          "bbox": [
            448.0,
            426.0,
            1533.0,
            468.0
          ],
          "confidence": 0.9874931573867798
        },
        {
          "text": "(a) Appearances and Video.",
          "bbox": [
            446.0,
            539.0,
            957.0,
            585.0
          ],
          "confidence": 0.995305597782135
        },
        {
          "text": "(i) In order to ensure the success of the co-branded Licensed Products and maximize Net Sales of such Licensed Products to the",
          "bbox": [
            618.0,
            654.0,
            3027.0,
            696.0
          ],
          "confidence": 0.9958583116531372
        },
        {
          "text": "mutual benefit of the parties hereto, the Endorser agrees that he shall make four (4) personal appearances (\"Appearances') in the First Contract",
          "bbox": [
            277.0,
            711.0,
            3030.0,
            753.0
          ],
          "confidence": 0.9903939366340637
        },
        {
          "text": "Year on dates, times and places mutually agreed upon by the parties hereto. Endorser acknowledges that such Appearances in the First Contract",
          "bbox": [
            279.0,
            764.0,
            3031.0,
            810.0
          ],
          "confidence": 0.9920351505279541
        },
        {
          "text": "Year shall consist of: (i) one (1) appearance at an industry tradeshow to be mutually agreed by the parties, (ii) one (1) charity event with Arnold's",
          "bbox": [
            279.0,
            822.0,
            3029.0,
            864.0
          ],
          "confidence": 0.994310200214386
        },
        {
          "text": "All-Stars, (ii) one (1) appearance at the Arnold Classic, and (iv) one (1) corporate and public relations event(s) in 2013 to be mutually agreed by the",
          "bbox": [
            275.0,
            873.0,
            3029.0,
            926.0
          ],
          "confidence": 0.9892397522926331
        },
        {
          "text": "parties.",
          "bbox": [
            271.0,
            928.0,
            416.0,
            982.0
          ],
          "confidence": 0.9960875511169434
        },
        {
          "text": "(ii) The Endorser and MusclePharm may also agree to produce on dates, times and places mutually agreed upon by the parties",
          "bbox": [
            616.0,
            1047.0,
            3027.0,
            1089.0
          ],
          "confidence": 0.9908355474472046
        },
        {
          "text": "hereto a GetSwole training video (the \"Training Video\") during a production session (the \"Production Day'). In the event that Endorser shall agree",
          "bbox": [
            274.0,
            1100.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9878440499305725
        },
        {
          "text": "to produce the Training Video (such decision shall be made by the Endorser exercisable in his sole discretion) and Products (other than the",
          "bbox": [
            277.0,
            1157.0,
            3025.0,
            1201.0
          ],
          "confidence": 0.9929729700088501
        },
        {
          "text": "Licensed Products) are featured and sold in connection with such Training Video then Endorser shall receive ten percent (10%) of Net Sales (as",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9952237010002136
        },
        {
          "text": "defined below) from the sale of any Products other than the Licensed Products featured and sold directly in conjunction with the Training Video..",
          "bbox": [
            279.0,
            1272.0,
            2960.0,
            1314.0
          ],
          "confidence": 0.9953819513320923
        },
        {
          "text": "(iii) In order to ensure the success of the co-branded Licensed Products and maximize Net Sales of such Licensed Products to the",
          "bbox": [
            616.0,
            1383.0,
            3027.0,
            1425.0
          ],
          "confidence": 0.99439537525177
        },
        {
          "text": "mutual benefit of the parties hereto, the Endorser agrees that he shall make two (2) Appearances in each of the Second Contract Year and Third",
          "bbox": [
            274.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9870166182518005
        },
        {
          "text": "Contract Year (and any subsequent Contract Years if applicable) on dates, times and places mutually agreed upon by the parties hereto (one such",
          "bbox": [
            279.0,
            1497.0,
            3027.0,
            1539.0
          ],
          "confidence": 0.9851273894309998
        },
        {
          "text": "appearance to include the Arnold Classic in each such Contract Year).",
          "bbox": [
            277.0,
            1548.0,
            1579.0,
            1597.0
          ],
          "confidence": 0.9984747767448425
        },
        {
          "text": "(iv) Each Appearance may be up to two (2) hours in length not including travel time to and from the Appearance, as scheduled by",
          "bbox": [
            616.0,
            1665.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9926900863647461
        },
        {
          "text": "MusclePharm, for the purpose or promoting MusclePharm, its Products and the Licensed Products. The Production Day shall be for the purpose of",
          "bbox": [
            275.0,
            1718.0,
            3032.0,
            1763.0
          ],
          "confidence": 0.9949948191642761
        },
        {
          "text": "MusclePharm shooting the Training Video. In the event that the Endorser agrees to participate in the Training Video, the Production Day for the",
          "bbox": [
            277.0,
            1776.0,
            3027.0,
            1820.0
          ],
          "confidence": 0.9919431209564209
        },
        {
          "text": "Training Video may be up to two (2) hours in duration..",
          "bbox": [
            279.0,
            1833.0,
            1281.0,
            1875.0
          ],
          "confidence": 0.9979972243309021
        },
        {
          "text": "(v) In the event Endorser agrees to appear in the Training Video on television promoting the Licensed Products during the Term",
          "bbox": [
            613.0,
            1942.0,
            3025.0,
            1988.0
          ],
          "confidence": 0.9938262701034546
        },
        {
          "text": "hereof, the Training Video shall be produced by a production company that is a SAG signatory and such production company shall pay on behalf",
          "bbox": [
            277.0,
            2001.0,
            3030.0,
            2043.0
          ],
          "confidence": 0.9962542057037354
        },
        {
          "text": "of the Endorser all pension, health & welfare benefit payments. For the purpose of computing such pension, health and welfare benefit",
          "bbox": [
            277.0,
            2058.0,
            3029.0,
            2100.0
          ],
          "confidence": 0.9924057126045227
        },
        {
          "text": "contributions and any other payments under any SAG or AFTRA contracts applicable to Endorser's appearance in such Training Video, 25% of the",
          "bbox": [
            279.0,
            2114.0,
            3027.0,
            2156.0
          ],
          "confidence": 0.9946678280830383
        },
        {
          "text": "compensation payable to Endorser under this Agreement shall be allocated as fair and reasonable consideration for Endorser's work and",
          "bbox": [
            279.0,
            2165.0,
            3029.0,
            2213.0
          ],
          "confidence": 0.9938332438468933
        },
        {
          "text": "appearance in the Training Video during the Term or thereafter during the Use-Up Period defined below.",
          "bbox": [
            277.0,
            2224.0,
            2197.0,
            2270.0
          ],
          "confidence": 0.994814395904541
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9972653388977051
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "4. Appearances, Advertising and Promotional Activities:.",
          "page": 3,
          "bbox": [
            448.0,
            426.0,
            1533.0,
            468.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Competitive Restriction Exception_4_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "Notwithstanding the foregoing, the following will not be a breach of this Agreement: (i) Endorser's performance of services or appearing in the news or informational portion of any radio, TV or film or entertainment program regardless of products or services therein or sponsorship thereof; (ii) Endorser's participation in movies or TV programs as well as merchandising, commercial tie-ins and/or product placements utilizing Endorser, or (iii) Endorser's performance of services, appearance or use of his name, likeness in connection with charitable events, sports events, organizations, regardless of usage of products or services and/or sponsorship thereof.",
      "page_number": 4,
      "words": [
        {
          "text": "(b) Advertisements, Print Media, and Promotional Items. Endorser agrees that during the Term MusclePharm shall have the right to use,",
          "bbox": [
            446.0,
            422.0,
            3027.0,
            470.0
          ],
          "confidence": 0.9913925528526306
        },
        {
          "text": "worldwide, Endorser's Name and Appearance Rights (as specified in Section 6) to advertise MusclePharm and its Products and Licensed Products",
          "bbox": [
            279.0,
            482.0,
            3029.0,
            524.0
          ],
          "confidence": 0.9893655776977539
        },
        {
          "text": "in print media, and in all other forms of media (other than telephone marketing or texting campaigns) including, but not limited to, point of sale",
          "bbox": [
            277.0,
            539.0,
            3027.0,
            581.0
          ],
          "confidence": 0.9928837418556213
        },
        {
          "text": "material, premiums and novelties, direct marketing material, and radio, television, electronic, and computer media (including but not limited to",
          "bbox": [
            279.0,
            598.0,
            3025.0,
            634.0
          ],
          "confidence": 0.9911594390869141
        },
        {
          "text": "MusclePharm's Internet and social media websites). Print media will also include promotional items on which Endorser's approved picture;",
          "bbox": [
            275.0,
            645.0,
            3027.0,
            694.0
          ],
          "confidence": 0.9990534782409668
        },
        {
          "text": "approved likeness, or facsimile signature may appear. Endorser will have the right to approve, in writing via his representative's office, all",
          "bbox": [
            279.0,
            707.0,
            3027.0,
            751.0
          ],
          "confidence": 0.9921228289604187
        },
        {
          "text": "advertising materials which utilize Endorser's Name and Appearance Rights, but Endorser will not unreasonably withhold approval and will",
          "bbox": [
            279.0,
            762.0,
            3029.0,
            806.0
          ],
          "confidence": 0.9964532256126404
        },
        {
          "text": "promptly respond to all approval requests..",
          "bbox": [
            281.0,
            820.0,
            1066.0,
            863.0
          ],
          "confidence": 0.9787991642951965
        },
        {
          "text": "(c) Use of Endorsements. During the Term, MusclePharm also shall have the right to use, worldwide, Endorser's oral or written",
          "bbox": [
            446.0,
            932.0,
            3029.0,
            974.0
          ],
          "confidence": 0.9899465441703796
        },
        {
          "text": "endorsements of Products and Licensed Products, or paraphrases thereof, to promote MusclePharm, its business, Products, and Licensed",
          "bbox": [
            279.0,
            987.0,
            3029.0,
            1029.0
          ],
          "confidence": 0.9990088939666748
        },
        {
          "text": "Products. Endorser shall have the right to approve such oral or written endorsements and the use thereof, such approval not to be unreasonably",
          "bbox": [
            277.0,
            1042.0,
            3025.0,
            1084.0
          ],
          "confidence": 0.9965783953666687
        },
        {
          "text": "withheld or delayed.",
          "bbox": [
            279.0,
            1100.0,
            651.0,
            1137.0
          ],
          "confidence": 0.9831833839416504
        },
        {
          "text": "(d) Use-Up Period. During the Term, the right to use Endorser's Name and Appearance Rights granted to MusclePharm in this Section",
          "bbox": [
            448.0,
            1212.0,
            3027.0,
            1254.0
          ],
          "confidence": 0.9915633201599121
        },
        {
          "text": "shall extend for six (6) months beyond the expiration of this Agreement (the \"Use-up Period\"). MusclePharm shall create no new advertising during",
          "bbox": [
            277.0,
            1265.0,
            3025.0,
            1312.0
          ],
          "confidence": 0.9935967922210693
        },
        {
          "text": "the Use-up Period using Endorser's Name and Appearance, but shall have the right to use during the Use-up Period Endorser's Name and",
          "bbox": [
            279.0,
            1321.0,
            3029.0,
            1367.0
          ],
          "confidence": 0.9940200448036194
        },
        {
          "text": "Appearance in advertisements and promotional materials created before the expiration date of this Agreement..",
          "bbox": [
            283.0,
            1380.0,
            2327.0,
            1422.0
          ],
          "confidence": 0.9914315342903137
        },
        {
          "text": "(e) Promotional Products. During the Term, MusclePharm shall have the right to create and distribute the Promotional Products world-",
          "bbox": [
            446.0,
            1487.0,
            3023.0,
            1535.0
          ],
          "confidence": 0.9938026070594788
        },
        {
          "text": "wide. MusclePharm shall be permitted to sell the Promotional Products at its cost to third parties and Endorser shall not be entitled to any.",
          "bbox": [
            272.0,
            1540.0,
            3027.0,
            1595.0
          ],
          "confidence": 0.9916924834251404
        },
        {
          "text": "additional compensation with respect to the Promotional Products. In the event that MusclePharm shall sell any Promotional Products above its",
          "bbox": [
            279.0,
            1604.0,
            3027.0,
            1646.0
          ],
          "confidence": 0.9979550838470459
        },
        {
          "text": "cost then Endorser shall be entitled to receive 10% of Net Sales from the sale of such Promotional Products..",
          "bbox": [
            281.0,
            1663.0,
            2276.0,
            1699.0
          ],
          "confidence": 0.9840759634971619
        },
        {
          "text": "(f) Online content. During the Term, Endorser will use good faith efforts to provide online content for MusclePharm's websites and social",
          "bbox": [
            446.0,
            1769.0,
            3029.0,
            1815.0
          ],
          "confidence": 0.9926746487617493
        },
        {
          "text": "media websites as reasonably requested by MusclePharm. This will be in a form agreed to by the parties (e.g. training video or video interview with",
          "bbox": [
            277.0,
            1829.0,
            3029.0,
            1873.0
          ],
          "confidence": 0.9945536255836487
        },
        {
          "text": "a MusclePharm representative). This will be scheduled so as to not interfere with Endorser's movie and other obligations. Endorser will use good",
          "bbox": [
            279.0,
            1888.0,
            3027.0,
            1924.0
          ],
          "confidence": 0.9958224892616272
        },
        {
          "text": "faith efforts to promote MusclePharm on his website (e.g. www.schwarzenegger.com).",
          "bbox": [
            279.0,
            1942.0,
            1867.0,
            1983.0
          ],
          "confidence": 0.9989922642707825
        },
        {
          "text": "(g) GetSwole. Endorser, in conjunction with MusclePharm's management and fitness experts will help in the design of the GetSwole Diet.",
          "bbox": [
            444.0,
            2050.0,
            3027.0,
            2098.0
          ],
          "confidence": 0.9954627752304077
        },
        {
          "text": "and Weight Training Program..",
          "bbox": [
            277.0,
            2107.0,
            832.0,
            2155.0
          ],
          "confidence": 0.9787854552268982
        },
        {
          "text": "(h) Autographed Items. Endorser shall also supply MusclePharm with at least fifty (50) signed items for each Contract Year, on the",
          "bbox": [
            446.0,
            2222.0,
            3027.0,
            2264.0
          ],
          "confidence": 0.9927880167961121
        },
        {
          "text": "Licensed Products or on other items to be mutually agreed upon by the parties hereto, to be used by MusclePharm in connection with the",
          "bbox": [
            277.0,
            2275.0,
            3025.0,
            2319.0
          ],
          "confidence": 0.9877569675445557
        },
        {
          "text": "promotion of the Products and/or Licensed Products..",
          "bbox": [
            277.0,
            2332.0,
            1269.0,
            2377.0
          ],
          "confidence": 0.9913474321365356
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9976211786270142
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Competitive Restriction Exception_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "Notwithstanding the foregoing or anything else contained herein, this Agreement shall not prevent or shall in any manner restrict Endorser from advertising, marketing and or endorsing products (or other companies which manufacture such products) which incidentally contain dietary supplements (including without limitation protein, vitamins, minerals, amino acids, herbs, legal performance enhancing substances) provided the primary purpose of such product or company is not to sell or market a dietary supplement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Competitive Restriction Exception_2_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.",
      "answer_text": "Notwithstanding the foregoing or anything else contained herein, this Agreement shall not prevent or shall in any manner restrict Endorser from advertising, marketing and or endorsing products (or other companies which manufacture such products) which incidentally contain dietary supplements (including without limitation protein, vitamins, minerals, amino acids, herbs, legal performance enhancing substances) provided the primary purpose of such product or company is not to sell or market a dietary supplement.",
      "page_number": 2,
      "words": [
        {
          "text": "(b) Products. As used in this Agreement, \"Products\" shall mean dietary supplements manufactured within the fifty states of the United",
          "bbox": [
            448.0,
            426.0,
            3029.0,
            468.0
          ],
          "confidence": 0.9876304864883423
        },
        {
          "text": "States of America; provided, however, MusclePharm shall not produce during the Term (and any renewal Term, if any) any diet pills and/or sexual",
          "bbox": [
            279.0,
            482.0,
            3029.0,
            524.0
          ],
          "confidence": 0.994454026222229
        },
        {
          "text": "enhancement products; provided, further, that fat burning products, Shred Matrix and Live Shredded products and products that increase",
          "bbox": [
            281.0,
            539.0,
            3029.0,
            581.0
          ],
          "confidence": 0.9972802996635437
        },
        {
          "text": "testosterone levels currently produced by MusclePharm as of the date hereof shall be part of the definition of Products for the purpose of this.",
          "bbox": [
            275.0,
            592.0,
            3027.0,
            638.0
          ],
          "confidence": 0.9937463402748108
        },
        {
          "text": "Agreement.",
          "bbox": [
            279.0,
            651.0,
            495.0,
            694.0
          ],
          "confidence": 0.9572042226791382
        },
        {
          "text": "(c) New Products. During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and",
          "bbox": [
            448.0,
            762.0,
            3029.0,
            804.0
          ],
          "confidence": 0.9988813400268555
        },
        {
          "text": "introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual.",
          "bbox": [
            277.0,
            819.0,
            3027.0,
            859.0
          ],
          "confidence": 0.9903531074523926
        },
        {
          "text": "sample of such new Product (the \"Sample') and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm",
          "bbox": [
            275.0,
            873.0,
            3029.0,
            917.0
          ],
          "confidence": 0.9890959858894348
        },
        {
          "text": "within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no",
          "bbox": [
            281.0,
            934.0,
            3027.0,
            970.0
          ],
          "confidence": 0.9913779497146606
        },
        {
          "text": "less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written",
          "bbox": [
            276.0,
            985.0,
            3029.0,
            1027.0
          ],
          "confidence": 0.9907599091529846
        },
        {
          "text": "agreement of the parties hereto.",
          "bbox": [
            279.0,
            1045.0,
            866.0,
            1085.0
          ],
          "confidence": 0.9954173564910889
        },
        {
          "text": "(d) Distribution Channels - Licensed Products. Subject to the terms and conditions herein (including the Exhibits), the license to",
          "bbox": [
            448.0,
            1155.0,
            3027.0,
            1197.0
          ],
          "confidence": 0.9957139492034912
        },
        {
          "text": "MusclePharm with respect to distribution and promotion of the Licensed Products is on a worldwide basis through the Distribution Channels (as",
          "bbox": [
            277.0,
            1212.0,
            3027.0,
            1254.0
          ],
          "confidence": 0.9994755983352661
        },
        {
          "text": "defined below) subject to approval rights set forth in Section 13 herein. For the purposes of this Agreement, \"Distribution Channels\"' means the",
          "bbox": [
            279.0,
            1268.0,
            3027.0,
            1310.0
          ],
          "confidence": 0.9890642166137695
        },
        {
          "text": "distribution of the Licensed Products through GNC retail and online chains worldwide during the First Contract Year and, thereafter, through",
          "bbox": [
            277.0,
            1321.0,
            3025.0,
            1367.0
          ],
          "confidence": 0.988422691822052
        },
        {
          "text": "MusclePharm's other worldwide distribution channels, as mutually determined by MusclePharm and the AS Parties.",
          "bbox": [
            277.0,
            1380.0,
            2431.0,
            1422.0
          ],
          "confidence": 0.9945962429046631
        },
        {
          "text": "3. Endorsement of Products:",
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ],
          "confidence": 0.9750658869743347
        },
        {
          "text": "Endorser agrees that he will use and evaluate the Products and Licensed Products according to the recommended use and dose",
          "bbox": [
            446.0,
            1606.0,
            3027.0,
            1650.0
          ],
          "confidence": 0.9927414059638977
        },
        {
          "text": "guidelines. Based on Endorser's knowledge, personal use and experience with the Products and Licensed Products that he shall from time to time",
          "bbox": [
            279.0,
            1661.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9863718748092651
        },
        {
          "text": "during the Term of this Agreement provide his honest evaluation, opinion, and findings about the Products and Licensed Products he is endorsing",
          "bbox": [
            277.0,
            1718.0,
            3027.0,
            1763.0
          ],
          "confidence": 0.992676854133606
        },
        {
          "text": "and promoting. The endorsements must be based on Endorser's knowledge and/or personal use and experience with the Products and Licensed",
          "bbox": [
            279.0,
            1776.0,
            3029.0,
            1818.0
          ],
          "confidence": 0.995076060295105
        },
        {
          "text": "Products at or about the times the endorsements are made. Endorser's statements and endorsements, or paraphrases thereof, may be used by",
          "bbox": [
            275.0,
            1829.0,
            3025.0,
            1875.0
          ],
          "confidence": 0.991610586643219
        },
        {
          "text": "MusclePharm to advertise, promote and publicize its business, Products and Licensed Products as provided herein. Endorser's endorsements of.",
          "bbox": [
            275.0,
            1886.0,
            3032.0,
            1932.0
          ],
          "confidence": 0.9898184537887573
        },
        {
          "text": "the Products and Licensed Products will be in accordance with the guidelines established by the Federal Trade Commission for endorsements in.",
          "bbox": [
            279.0,
            1944.0,
            3027.0,
            1985.0
          ],
          "confidence": 0.9928502440452576
        },
        {
          "text": "advertising. If requested by MusclePharm, Endorser shall provide a signed affidavit in form satisfactory to MusclePharm confirming Endorser's",
          "bbox": [
            277.0,
            1999.0,
            3029.0,
            2043.0
          ],
          "confidence": 0.9966766238212585
        },
        {
          "text": "compliance with the FTC standards in connection with his endorsements and endorsement activities..",
          "bbox": [
            281.0,
            2058.0,
            2155.0,
            2100.0
          ],
          "confidence": 0.9970789551734924
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9981697797775269
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "3. Endorsement of Products:",
          "page": 2,
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Rofr/Rofo/Rofn_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Rofr/Rofo/Rofn\" that should be reviewed by a lawyer. Details: Is there a clause granting one party a right of first refusal, right of first offer or right of first negotiation to purchase, license, market, or distribute equity interest, technology, assets, products or services?",
      "answer_text": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Rofr/Rofo/Rofn_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Rofr/Rofo/Rofn\" that should be reviewed by a lawyer. Details: Is there a clause granting one party a right of first refusal, right of first offer or right of first negotiation to purchase, license, market, or distribute equity interest, technology, assets, products or services?",
      "answer_text": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Change Of Control_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Change Of Control_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "Nothwithstanding the foregoing, this Agreement may be assigned without the AS Parties' consent by MusclePharm in connection with a change of control transaction; provided that the acquirer of MusclePharm shall have financial resources substantially similar or greater than MusclePharm and shall specifically assume the obligations of MusclePharm under this Agreement in writing prior to the consummation of the change of control transaction.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Change Of Control_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Change Of Control_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_0",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "The license granted by this Agreement is personal to MusclePharm.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_5",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Any attempted assignment or transfer by a party of their rights and/or obligations without such consent shall be void.",
      "page_number": 5,
      "words": [
        {
          "text": "(i) Representations and Warranties. Endorser expressly represents and warrants that he is not subject to any restriction or limitation by.",
          "bbox": [
            448.0,
            424.0,
            3025.0,
            468.0
          ],
          "confidence": 0.9970143437385559
        },
        {
          "text": "way of employment or contractual obligation that may impair or limit his performance of the advertising and promotional activities described above.",
          "bbox": [
            281.0,
            482.0,
            3023.0,
            524.0
          ],
          "confidence": 0.993423342704773
        },
        {
          "text": "and that Endorser has the express approval of any third party to make the promises and commitments set forth herein, and will advise any future",
          "bbox": [
            281.0,
            539.0,
            3027.0,
            583.0
          ],
          "confidence": 0.9957323670387268
        },
        {
          "text": "employer of his obligations hereunder.",
          "bbox": [
            281.0,
            594.0,
            992.0,
            636.0
          ],
          "confidence": 0.983302891254425
        },
        {
          "text": "5. Scheduling:",
          "bbox": [
            444.0,
            703.0,
            720.0,
            751.0
          ],
          "confidence": 0.9458659887313843
        },
        {
          "text": "(a) The Appearances, the Production Day, the Licensed Product launch and related media campaign, the interview of Endorser by",
          "bbox": [
            446.0,
            822.0,
            3027.0,
            864.0
          ],
          "confidence": 0.9961044788360596
        },
        {
          "text": "MusclePharm, and all advertising and promotional activities requested by MusclePharm and approved by Endorser shall be scheduled by mutual.",
          "bbox": [
            277.0,
            879.0,
            3029.0,
            921.0
          ],
          "confidence": 0.9978381991386414
        },
        {
          "text": "agreement and subject to Endorser's other business activities and commitments occurring during the Term of this Agreement. Endorser's",
          "bbox": [
            275.0,
            930.0,
            3027.0,
            979.0
          ],
          "confidence": 0.9986559748649597
        },
        {
          "text": "commitments pursuant to this Agreement shall be scheduled so as not to conflict with Endorser's other commitments. Endorser agrees that he will.",
          "bbox": [
            277.0,
            990.0,
            3029.0,
            1032.0
          ],
          "confidence": 0.9932000637054443
        },
        {
          "text": "in good faith make every reasonable effort, given his other commitments, to give priority to the fulfillment of his obligations pursuant to this",
          "bbox": [
            281.0,
            1051.0,
            3027.0,
            1087.0
          ],
          "confidence": 0.993504524230957
        },
        {
          "text": "Agreement. The parties shall confer periodically for the purpose of coordinating and scheduling Endorser's advertising and promotional activities",
          "bbox": [
            281.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9946132302284241
        },
        {
          "text": "and services.",
          "bbox": [
            277.0,
            1160.0,
            524.0,
            1199.0
          ],
          "confidence": 0.9941328763961792
        },
        {
          "text": "6. Right of Publicity:",
          "bbox": [
            446.0,
            1272.0,
            845.0,
            1316.0
          ],
          "confidence": 0.9977350234985352
        },
        {
          "text": "(a) Name and Appearance Rights. As provided below, during the Term, the AS Parties grant to MusclePharm the right to use the",
          "bbox": [
            448.0,
            1387.0,
            3027.0,
            1429.0
          ],
          "confidence": 0.9923115372657776
        },
        {
          "text": "Trademarks as defined in this Agreement and the Name and Appearance Rights, which shall include Endorser's name, approved photograph,",
          "bbox": [
            275.0,
            1440.0,
            3025.0,
            1487.0
          ],
          "confidence": 0.9966827630996704
        },
        {
          "text": "approved picture (including, without limitation, any copyrighted pictures and video images of the Endorser owned by the Endorser which Endorser.",
          "bbox": [
            279.0,
            1497.0,
            3031.0,
            1544.0
          ],
          "confidence": 0.9976984858512878
        },
        {
          "text": "agrees to make available for use hereunder), approved appearance, or approved likeness, including video and other recordings of Endorser's.",
          "bbox": [
            275.0,
            1550.0,
            3029.0,
            1603.0
          ],
          "confidence": 0.9911730885505676
        },
        {
          "text": "appearance, along with the right to use Endorser's voice, including audio or other recordings of Endorser's voice, Endorser's signature, personal or.",
          "bbox": [
            274.0,
            1608.0,
            3031.0,
            1659.0
          ],
          "confidence": 0.9934909343719482
        },
        {
          "text": "professional background and experience, reputation, approved quotations and approved endorsements, or approved paraphrases of Endorser's.",
          "bbox": [
            275.0,
            1667.0,
            3029.0,
            1712.0
          ],
          "confidence": 0.9919371008872986
        },
        {
          "text": "approved quotations and endorsements, including approved touch-ups, approved simulations or approved compositions of any of the above",
          "bbox": [
            279.0,
            1725.0,
            3027.0,
            1769.0
          ],
          "confidence": 0.9882649779319763
        },
        {
          "text": "acknowledges that the use of some works may require that MusclePharm obtain a copyright license from third parties.",
          "bbox": [
            279.0,
            1836.0,
            2469.0,
            1879.0
          ],
          "confidence": 0.9976282715797424
        },
        {
          "text": "(b) Promotional Uses. During the Term of this Agreement, the AS Parties grant to MusclePharm and consent to MusclePharm's commercial",
          "bbox": [
            446.0,
            1946.0,
            3029.0,
            1990.0
          ],
          "confidence": 0.9852160811424255
        },
        {
          "text": "use of the Name and Appearance Rights to advertise, promote, endorse and publicize Products, Licensed Products, and MusclePharm's business,.",
          "bbox": [
            275.0,
            2003.0,
            3027.0,
            2047.0
          ],
          "confidence": 0.99473637342453
        },
        {
          "text": "worldwide in any media selected by MusclePharm (excluding telephone or texting campaigns), including but not limited to print, radio, television,",
          "bbox": [
            275.0,
            2059.0,
            3025.0,
            2105.0
          ],
          "confidence": 0.9986136555671692
        },
        {
          "text": "electronic, wireless or internet, pursuant to the terms and conditions set forth herein. MusclePharm acknowledges that any use on products",
          "bbox": [
            279.0,
            2118.0,
            3029.0,
            2160.0
          ],
          "confidence": 0.9976794719696045
        },
        {
          "text": "requires approval and that use of the Name and Appearance Rights on products is limited to the Licensed Products..",
          "bbox": [
            275.0,
            2171.0,
            2436.0,
            2217.0
          ],
          "confidence": 0.9954543709754944
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9983269572257996
        }
      ],
      "nearby_headers": [
        {
          "text": "5. Scheduling:",
          "page": 5,
          "bbox": [
            444.0,
            703.0,
            720.0,
            751.0
          ]
        },
        {
          "text": "6. Right of Publicity:",
          "page": 5,
          "bbox": [
            446.0,
            1272.0,
            845.0,
            1316.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Except as set forth below, MusclePharm shall not assign or otherwise transfer, license, sublicense, or delegate any rights or obligations under this Agreement without the express prior written consent of the AS Parties.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Except as set forth below, MusclePharm shall not assign or otherwise transfer, license, sublicense, or delegate any rights or obligations under this Agreement without the express prior written consent of the AS Parties.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Neither party shall voluntarily or by operation of law assign or otherwise transfer the rights and/or obligations incurred pursuant to the terms of this Agreement without the prior written consent of the other party.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "This Agreement may also be terminated by MusclePharm, upon fifteen days prior written notice, if death, or physical disability, physical injury, or other incapacity lasting more than eight (8) weeks, causes Endorser to be unable to perform a material amount of the personal or consulting services described in this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Anti-Assignment_2_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "This Agreement may also be terminated by MusclePharm, upon fifteen days prior written notice, if death, or physical disability, physical injury, or other incapacity lasting more than eight (8) weeks, causes Endorser to be unable to perform a material amount of the personal or consulting services described in this Agreement.",
      "page_number": 2,
      "words": [
        {
          "text": "(b) Products. As used in this Agreement, \"Products\" shall mean dietary supplements manufactured within the fifty states of the United",
          "bbox": [
            448.0,
            426.0,
            3029.0,
            468.0
          ],
          "confidence": 0.9876304864883423
        },
        {
          "text": "States of America; provided, however, MusclePharm shall not produce during the Term (and any renewal Term, if any) any diet pills and/or sexual",
          "bbox": [
            279.0,
            482.0,
            3029.0,
            524.0
          ],
          "confidence": 0.994454026222229
        },
        {
          "text": "enhancement products; provided, further, that fat burning products, Shred Matrix and Live Shredded products and products that increase",
          "bbox": [
            281.0,
            539.0,
            3029.0,
            581.0
          ],
          "confidence": 0.9972802996635437
        },
        {
          "text": "testosterone levels currently produced by MusclePharm as of the date hereof shall be part of the definition of Products for the purpose of this.",
          "bbox": [
            275.0,
            592.0,
            3027.0,
            638.0
          ],
          "confidence": 0.9937463402748108
        },
        {
          "text": "Agreement.",
          "bbox": [
            279.0,
            651.0,
            495.0,
            694.0
          ],
          "confidence": 0.9572042226791382
        },
        {
          "text": "(c) New Products. During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and",
          "bbox": [
            448.0,
            762.0,
            3029.0,
            804.0
          ],
          "confidence": 0.9988813400268555
        },
        {
          "text": "introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual.",
          "bbox": [
            277.0,
            819.0,
            3027.0,
            859.0
          ],
          "confidence": 0.9903531074523926
        },
        {
          "text": "sample of such new Product (the \"Sample') and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm",
          "bbox": [
            275.0,
            873.0,
            3029.0,
            917.0
          ],
          "confidence": 0.9890959858894348
        },
        {
          "text": "within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no",
          "bbox": [
            281.0,
            934.0,
            3027.0,
            970.0
          ],
          "confidence": 0.9913779497146606
        },
        {
          "text": "less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written",
          "bbox": [
            276.0,
            985.0,
            3029.0,
            1027.0
          ],
          "confidence": 0.9907599091529846
        },
        {
          "text": "agreement of the parties hereto.",
          "bbox": [
            279.0,
            1045.0,
            866.0,
            1085.0
          ],
          "confidence": 0.9954173564910889
        },
        {
          "text": "(d) Distribution Channels - Licensed Products. Subject to the terms and conditions herein (including the Exhibits), the license to",
          "bbox": [
            448.0,
            1155.0,
            3027.0,
            1197.0
          ],
          "confidence": 0.9957139492034912
        },
        {
          "text": "MusclePharm with respect to distribution and promotion of the Licensed Products is on a worldwide basis through the Distribution Channels (as",
          "bbox": [
            277.0,
            1212.0,
            3027.0,
            1254.0
          ],
          "confidence": 0.9994755983352661
        },
        {
          "text": "defined below) subject to approval rights set forth in Section 13 herein. For the purposes of this Agreement, \"Distribution Channels\"' means the",
          "bbox": [
            279.0,
            1268.0,
            3027.0,
            1310.0
          ],
          "confidence": 0.9890642166137695
        },
        {
          "text": "distribution of the Licensed Products through GNC retail and online chains worldwide during the First Contract Year and, thereafter, through",
          "bbox": [
            277.0,
            1321.0,
            3025.0,
            1367.0
          ],
          "confidence": 0.988422691822052
        },
        {
          "text": "MusclePharm's other worldwide distribution channels, as mutually determined by MusclePharm and the AS Parties.",
          "bbox": [
            277.0,
            1380.0,
            2431.0,
            1422.0
          ],
          "confidence": 0.9945962429046631
        },
        {
          "text": "3. Endorsement of Products:",
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ],
          "confidence": 0.9750658869743347
        },
        {
          "text": "Endorser agrees that he will use and evaluate the Products and Licensed Products according to the recommended use and dose",
          "bbox": [
            446.0,
            1606.0,
            3027.0,
            1650.0
          ],
          "confidence": 0.9927414059638977
        },
        {
          "text": "guidelines. Based on Endorser's knowledge, personal use and experience with the Products and Licensed Products that he shall from time to time",
          "bbox": [
            279.0,
            1661.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9863718748092651
        },
        {
          "text": "during the Term of this Agreement provide his honest evaluation, opinion, and findings about the Products and Licensed Products he is endorsing",
          "bbox": [
            277.0,
            1718.0,
            3027.0,
            1763.0
          ],
          "confidence": 0.992676854133606
        },
        {
          "text": "and promoting. The endorsements must be based on Endorser's knowledge and/or personal use and experience with the Products and Licensed",
          "bbox": [
            279.0,
            1776.0,
            3029.0,
            1818.0
          ],
          "confidence": 0.995076060295105
        },
        {
          "text": "Products at or about the times the endorsements are made. Endorser's statements and endorsements, or paraphrases thereof, may be used by",
          "bbox": [
            275.0,
            1829.0,
            3025.0,
            1875.0
          ],
          "confidence": 0.991610586643219
        },
        {
          "text": "MusclePharm to advertise, promote and publicize its business, Products and Licensed Products as provided herein. Endorser's endorsements of.",
          "bbox": [
            275.0,
            1886.0,
            3032.0,
            1932.0
          ],
          "confidence": 0.9898184537887573
        },
        {
          "text": "the Products and Licensed Products will be in accordance with the guidelines established by the Federal Trade Commission for endorsements in.",
          "bbox": [
            279.0,
            1944.0,
            3027.0,
            1985.0
          ],
          "confidence": 0.9928502440452576
        },
        {
          "text": "advertising. If requested by MusclePharm, Endorser shall provide a signed affidavit in form satisfactory to MusclePharm confirming Endorser's",
          "bbox": [
            277.0,
            1999.0,
            3029.0,
            2043.0
          ],
          "confidence": 0.9966766238212585
        },
        {
          "text": "compliance with the FTC standards in connection with his endorsements and endorsement activities..",
          "bbox": [
            281.0,
            2058.0,
            2155.0,
            2100.0
          ],
          "confidence": 0.9970789551734924
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9981697797775269
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "3. Endorsement of Products:",
          "page": 2,
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Revenue/Profit Sharing_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or services?",
      "answer_text": "In the event that Endorser shall agree to produce the Training Video (such decision shall be made by the Endorser exercisable in his sole discretion) and Products (other than the Licensed Products) are featured and sold in connection with such Training Video then Endorser shall receive ten percent (10%) of Net Sales (as defined below) from the sale of any Products other than the Licensed Products featured and sold directly in conjunction with the Training Video.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Revenue/Profit Sharing_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or services?",
      "answer_text": "In the event that Endorser shall agree to produce the Training Video (such decision shall be made by the Endorser exercisable in his sole discretion) and Products (other than the Licensed Products) are featured and sold in connection with such Training Video then Endorser shall receive ten percent (10%) of Net Sales (as defined below) from the sale of any Products other than the Licensed Products featured and sold directly in conjunction with the Training Video.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Revenue/Profit Sharing_1",
      "question": "Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or services?",
      "answer_text": "In the event that MusclePharm shall sell any Promotional Products above its cost then Endorser shall be entitled to receive 10% of Net Sales from the sale of such Promotional Products.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Revenue/Profit Sharing_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or services?",
      "answer_text": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Revenue/Profit Sharing_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or services?",
      "answer_text": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Notwithstanding the foregoing, Lender shall be entitled to receive a guaranteed minimum royalty for each Contract Year including the Additional Term, if any (the \"Guaranteed Minimum Royalty\"), payable in accordance with Exhibit \"C\" attached hereto.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_28_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2017; October 1, 2017; February 1, 2018 Six   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2018; October 1, 2018; February 1, 2019",
      "page_number": 28,
      "words": [
        {
          "text": "Exhibit \"B'",
          "bbox": [
            1539.0,
            420.0,
            1766.0,
            468.0
          ],
          "confidence": 0.9526094198226929
        },
        {
          "text": "Royalty Statement",
          "bbox": [
            1477.0,
            480.0,
            1834.0,
            528.0
          ],
          "confidence": 0.9998890161514282
        },
        {
          "text": "Company Name:MusclePharm Corporation",
          "bbox": [
            281.0,
            594.0,
            1093.0,
            636.0
          ],
          "confidence": 0.9998994469642639
        },
        {
          "text": "Licensee Address:4721 Ironton Street, Unit A, Denver, Colorado 80239",
          "bbox": [
            276.0,
            705.0,
            1590.0,
            747.0
          ],
          "confidence": 0.9928665161132812
        },
        {
          "text": "For Quarter Ending:",
          "bbox": [
            273.0,
            815.0,
            645.0,
            865.0
          ],
          "confidence": 0.999872624874115
        },
        {
          "text": "Item/SKU",
          "bbox": [
            634.0,
            924.0,
            825.0,
            972.0
          ],
          "confidence": 0.9995687007904053
        },
        {
          "text": "No.",
          "bbox": [
            1426.0,
            922.0,
            1512.0,
            977.0
          ],
          "confidence": 0.8913165926933289
        },
        {
          "text": "Customer",
          "bbox": [
            273.0,
            983.0,
            461.0,
            1031.0
          ],
          "confidence": 0.9999455213546753
        },
        {
          "text": "Number or",
          "bbox": [
            636.0,
            989.0,
            839.0,
            1027.0
          ],
          "confidence": 0.999945878982544
        },
        {
          "text": "Invoice",
          "bbox": [
            1185.0,
            983.0,
            1332.0,
            1029.0
          ],
          "confidence": 0.9997576475143433
        },
        {
          "text": "Units",
          "bbox": [
            1434.0,
            983.0,
            1546.0,
            1029.0
          ],
          "confidence": 0.9998245239257812
        },
        {
          "text": "Sales",
          "bbox": [
            1631.0,
            983.0,
            1738.0,
            1029.0
          ],
          "confidence": 0.9998493194580078
        },
        {
          "text": "Less",
          "bbox": [
            1873.0,
            981.0,
            1978.0,
            1031.0
          ],
          "confidence": 0.9996113181114197
        },
        {
          "text": "Net",
          "bbox": [
            2179.0,
            985.0,
            2258.0,
            1027.0
          ],
          "confidence": 0.9999017715454102
        },
        {
          "text": "Royalty",
          "bbox": [
            2368.0,
            981.0,
            2525.0,
            1037.0
          ],
          "confidence": 0.9998513460159302
        },
        {
          "text": "Royalty",
          "bbox": [
            2747.0,
            981.0,
            2906.0,
            1037.0
          ],
          "confidence": 0.999816358089447
        },
        {
          "text": "Name",
          "bbox": [
            270.0,
            1037.0,
            388.0,
            1088.0
          ],
          "confidence": 0.9998892545700073
        },
        {
          "text": "Description",
          "bbox": [
            636.0,
            1043.0,
            856.0,
            1087.0
          ],
          "confidence": 0.9999179244041443
        },
        {
          "text": "Price",
          "bbox": [
            1181.0,
            1035.0,
            1286.0,
            1088.0
          ],
          "confidence": 0.9998563528060913
        },
        {
          "text": "Sold",
          "bbox": [
            1431.0,
            1035.0,
            1530.0,
            1088.0
          ],
          "confidence": 0.9997397661209106
        },
        {
          "text": "Invoice",
          "bbox": [
            1628.0,
            1042.0,
            1780.0,
            1085.0
          ],
          "confidence": 0.9998186230659485
        },
        {
          "text": "Returns",
          "bbox": [
            1879.0,
            1041.0,
            2034.0,
            1086.0
          ],
          "confidence": 0.9999220967292786
        },
        {
          "text": "Sales",
          "bbox": [
            2182.0,
            1040.0,
            2287.0,
            1085.0
          ],
          "confidence": 0.9998496770858765
        },
        {
          "text": "Percentage",
          "bbox": [
            2369.0,
            1041.0,
            2585.0,
            1089.0
          ],
          "confidence": 0.9998930096626282
        },
        {
          "text": "Amount",
          "bbox": [
            2753.0,
            1045.0,
            2913.0,
            1084.0
          ],
          "confidence": 0.9999539256095886
        },
        {
          "text": "Total Royalty Earned This Quarter:.",
          "bbox": [
            281.0,
            1153.0,
            924.0,
            1199.0
          ],
          "confidence": 0.9921082854270935
        },
        {
          "text": "$",
          "bbox": [
            2212.0,
            1153.0,
            2251.0,
            1204.0
          ],
          "confidence": 0.9936621189117432
        },
        {
          "text": "Total Earned Royalty To Date (This Contract Year):",
          "bbox": [
            279.0,
            1274.0,
            1223.0,
            1318.0
          ],
          "confidence": 0.9923000335693359
        },
        {
          "text": "$",
          "bbox": [
            2217.0,
            1275.0,
            2248.0,
            1321.0
          ],
          "confidence": 0.9967209696769714
        },
        {
          "text": "TOTAL",
          "bbox": [
            277.0,
            1391.0,
            424.0,
            1436.0
          ],
          "confidence": 0.9997556805610657
        },
        {
          "text": "S",
          "bbox": [
            2217.0,
            1394.0,
            2249.0,
            1444.0
          ],
          "confidence": 0.644670844078064
        },
        {
          "text": "Less Paid and Un-Recouped Minimum Guarantee:.",
          "bbox": [
            281.0,
            1515.0,
            1200.0,
            1551.0
          ],
          "confidence": 0.9830753803253174
        },
        {
          "text": "$",
          "bbox": [
            2217.0,
            1509.0,
            2248.0,
            1555.0
          ],
          "confidence": 0.9946321249008179
        },
        {
          "text": "([D",
          "bbox": [
            2534.0,
            1509.0,
            2612.0,
            1562.0
          ],
          "confidence": 0.6601287126541138
        },
        {
          "text": "Balance Due From the Company and Payable This Quarter:.",
          "bbox": [
            281.0,
            1624.0,
            1367.0,
            1667.0
          ],
          "confidence": 0.9885050058364868
        },
        {
          "text": "$",
          "bbox": [
            2217.0,
            1626.0,
            2248.0,
            1670.0
          ],
          "confidence": 0.9972478747367859
        },
        {
          "text": "I hereby certify that the above is accurate and complete..",
          "bbox": [
            446.0,
            1745.0,
            1486.0,
            1787.0
          ],
          "confidence": 0.9839082956314087
        },
        {
          "text": "Signature",
          "bbox": [
            556.0,
            1915.0,
            734.0,
            1959.0
          ],
          "confidence": 0.9999518990516663
        },
        {
          "text": "Date",
          "bbox": [
            2060.0,
            1913.0,
            2157.0,
            1958.0
          ],
          "confidence": 0.9998319149017334
        },
        {
          "text": "Title",
          "bbox": [
            548.0,
            2022.0,
            641.0,
            2077.0
          ],
          "confidence": 0.9996421933174133
        },
        {
          "text": "Printed Name",
          "bbox": [
            554.0,
            2141.0,
            803.0,
            2189.0
          ],
          "confidence": 0.9998235702514648
        },
        {
          "text": "Submit to:",
          "bbox": [
            275.0,
            2255.0,
            468.0,
            2303.0
          ],
          "confidence": 0.9777308702468872
        },
        {
          "text": "Name:",
          "bbox": [
            271.0,
            2368.0,
            396.0,
            2413.0
          ],
          "confidence": 0.9997938871383667
        },
        {
          "text": "Email:",
          "bbox": [
            276.0,
            2425.0,
            392.0,
            2471.0
          ],
          "confidence": 0.9990415573120117
        },
        {
          "text": "Tel:",
          "bbox": [
            274.0,
            2485.0,
            348.0,
            2529.0
          ],
          "confidence": 0.9999179840087891
        },
        {
          "text": "Date Received:",
          "bbox": [
            277.0,
            2547.0,
            556.0,
            2586.0
          ],
          "confidence": 0.9998378157615662
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9971140027046204
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "TOTAL",
          "page": 28,
          "bbox": [
            277.0,
            1391.0,
            424.0,
            1436.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_29_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Guaranteed Minimum Royalty during the First Additional Term:   In the event that the Renewal Threshold is achieved in the Third Contract Year, during the First Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Four   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2016; October 1, 2016; February 1, 2017 Five   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2017; October 1, 2017; February 1, 2018 Six   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2018; October 1, 2018; February 1, 2019",
      "page_number": 29,
      "words": [
        {
          "text": "Exhibit\"C'",
          "bbox": [
            1539.0,
            422.0,
            1766.0,
            464.0
          ],
          "confidence": 0.9423649907112122
        },
        {
          "text": "Section (1)",
          "bbox": [
            442.0,
            533.0,
            656.0,
            581.0
          ],
          "confidence": 0.9598045945167542
        },
        {
          "text": "Guaranteed Minimum Royalty during the initial Term:",
          "bbox": [
            448.0,
            651.0,
            1432.0,
            693.0
          ],
          "confidence": 0.9998934864997864
        },
        {
          "text": "Contract Year",
          "bbox": [
            448.0,
            762.0,
            698.0,
            800.0
          ],
          "confidence": 0.9906719923019409
        },
        {
          "text": "Minimum Royalty",
          "bbox": [
            843.0,
            760.0,
            1175.0,
            804.0
          ],
          "confidence": 0.9979216456413269
        },
        {
          "text": "Timing of Payment",
          "bbox": [
            1430.0,
            764.0,
            1776.0,
            802.0
          ],
          "confidence": 0.9999237060546875
        },
        {
          "text": "One",
          "bbox": [
            442.0,
            822.0,
            528.0,
            869.0
          ],
          "confidence": 0.9998375773429871
        },
        {
          "text": "$1,500,000",
          "bbox": [
            845.0,
            824.0,
            1037.0,
            868.0
          ],
          "confidence": 0.9999626874923706
        },
        {
          "text": "$500,000 payment due on the following dates: July 23, 2013; October 1,",
          "bbox": [
            1426.0,
            826.0,
            2740.0,
            868.0
          ],
          "confidence": 0.9969886541366577
        },
        {
          "text": "2013; February 1, 2014",
          "bbox": [
            1428.0,
            881.0,
            1842.0,
            921.0
          ],
          "confidence": 0.997204065322876
        },
        {
          "text": "Two",
          "bbox": [
            438.0,
            933.0,
            530.0,
            980.0
          ],
          "confidence": 0.9986575245857239
        },
        {
          "text": "$2,000,000",
          "bbox": [
            845.0,
            936.0,
            1037.0,
            979.0
          ],
          "confidence": 0.9998959302902222
        },
        {
          "text": "$666,666.66 payment due on the following dates: July 23, 2014; October",
          "bbox": [
            1430.0,
            941.0,
            2750.0,
            978.0
          ],
          "confidence": 0.9964415431022644
        },
        {
          "text": "1, 2014; February 1, 2015",
          "bbox": [
            1426.0,
            990.0,
            1885.0,
            1036.0
          ],
          "confidence": 0.9955172538757324
        },
        {
          "text": "Three",
          "bbox": [
            440.0,
            1047.0,
            558.0,
            1093.0
          ],
          "confidence": 0.9998759031295776
        },
        {
          "text": "$2,500,000",
          "bbox": [
            846.0,
            1047.0,
            1037.0,
            1091.0
          ],
          "confidence": 0.9999494552612305
        },
        {
          "text": "$833,333.33 payment due on the following dates: July 23, 2015; October",
          "bbox": [
            1428.0,
            1051.0,
            2751.0,
            1093.0
          ],
          "confidence": 0.998781681060791
        },
        {
          "text": "1, 2015; February 1, 2016",
          "bbox": [
            1426.0,
            1104.0,
            1885.0,
            1149.0
          ],
          "confidence": 0.9957472085952759
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973068237304688
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_28_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2020; October 1, 2020; February 1, 2021 Nine   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2021; October 1, 2021; February 1, 2022",
      "page_number": 28,
      "words": [
        {
          "text": "Exhibit \"B'",
          "bbox": [
            1539.0,
            420.0,
            1766.0,
            468.0
          ],
          "confidence": 0.9526094198226929
        },
        {
          "text": "Royalty Statement",
          "bbox": [
            1477.0,
            480.0,
            1834.0,
            528.0
          ],
          "confidence": 0.9998890161514282
        },
        {
          "text": "Company Name:MusclePharm Corporation",
          "bbox": [
            281.0,
            594.0,
            1093.0,
            636.0
          ],
          "confidence": 0.9998994469642639
        },
        {
          "text": "Licensee Address:4721 Ironton Street, Unit A, Denver, Colorado 80239",
          "bbox": [
            276.0,
            705.0,
            1590.0,
            747.0
          ],
          "confidence": 0.9928665161132812
        },
        {
          "text": "For Quarter Ending:",
          "bbox": [
            273.0,
            815.0,
            645.0,
            865.0
          ],
          "confidence": 0.999872624874115
        },
        {
          "text": "Item/SKU",
          "bbox": [
            634.0,
            924.0,
            825.0,
            972.0
          ],
          "confidence": 0.9995687007904053
        },
        {
          "text": "No.",
          "bbox": [
            1426.0,
            922.0,
            1512.0,
            977.0
          ],
          "confidence": 0.8913165926933289
        },
        {
          "text": "Customer",
          "bbox": [
            273.0,
            983.0,
            461.0,
            1031.0
          ],
          "confidence": 0.9999455213546753
        },
        {
          "text": "Number or",
          "bbox": [
            636.0,
            989.0,
            839.0,
            1027.0
          ],
          "confidence": 0.999945878982544
        },
        {
          "text": "Invoice",
          "bbox": [
            1185.0,
            983.0,
            1332.0,
            1029.0
          ],
          "confidence": 0.9997576475143433
        },
        {
          "text": "Units",
          "bbox": [
            1434.0,
            983.0,
            1546.0,
            1029.0
          ],
          "confidence": 0.9998245239257812
        },
        {
          "text": "Sales",
          "bbox": [
            1631.0,
            983.0,
            1738.0,
            1029.0
          ],
          "confidence": 0.9998493194580078
        },
        {
          "text": "Less",
          "bbox": [
            1873.0,
            981.0,
            1978.0,
            1031.0
          ],
          "confidence": 0.9996113181114197
        },
        {
          "text": "Net",
          "bbox": [
            2179.0,
            985.0,
            2258.0,
            1027.0
          ],
          "confidence": 0.9999017715454102
        },
        {
          "text": "Royalty",
          "bbox": [
            2368.0,
            981.0,
            2525.0,
            1037.0
          ],
          "confidence": 0.9998513460159302
        },
        {
          "text": "Royalty",
          "bbox": [
            2747.0,
            981.0,
            2906.0,
            1037.0
          ],
          "confidence": 0.999816358089447
        },
        {
          "text": "Name",
          "bbox": [
            270.0,
            1037.0,
            388.0,
            1088.0
          ],
          "confidence": 0.9998892545700073
        },
        {
          "text": "Description",
          "bbox": [
            636.0,
            1043.0,
            856.0,
            1087.0
          ],
          "confidence": 0.9999179244041443
        },
        {
          "text": "Price",
          "bbox": [
            1181.0,
            1035.0,
            1286.0,
            1088.0
          ],
          "confidence": 0.9998563528060913
        },
        {
          "text": "Sold",
          "bbox": [
            1431.0,
            1035.0,
            1530.0,
            1088.0
          ],
          "confidence": 0.9997397661209106
        },
        {
          "text": "Invoice",
          "bbox": [
            1628.0,
            1042.0,
            1780.0,
            1085.0
          ],
          "confidence": 0.9998186230659485
        },
        {
          "text": "Returns",
          "bbox": [
            1879.0,
            1041.0,
            2034.0,
            1086.0
          ],
          "confidence": 0.9999220967292786
        },
        {
          "text": "Sales",
          "bbox": [
            2182.0,
            1040.0,
            2287.0,
            1085.0
          ],
          "confidence": 0.9998496770858765
        },
        {
          "text": "Percentage",
          "bbox": [
            2369.0,
            1041.0,
            2585.0,
            1089.0
          ],
          "confidence": 0.9998930096626282
        },
        {
          "text": "Amount",
          "bbox": [
            2753.0,
            1045.0,
            2913.0,
            1084.0
          ],
          "confidence": 0.9999539256095886
        },
        {
          "text": "Total Royalty Earned This Quarter:.",
          "bbox": [
            281.0,
            1153.0,
            924.0,
            1199.0
          ],
          "confidence": 0.9921082854270935
        },
        {
          "text": "$",
          "bbox": [
            2212.0,
            1153.0,
            2251.0,
            1204.0
          ],
          "confidence": 0.9936621189117432
        },
        {
          "text": "Total Earned Royalty To Date (This Contract Year):",
          "bbox": [
            279.0,
            1274.0,
            1223.0,
            1318.0
          ],
          "confidence": 0.9923000335693359
        },
        {
          "text": "$",
          "bbox": [
            2217.0,
            1275.0,
            2248.0,
            1321.0
          ],
          "confidence": 0.9967209696769714
        },
        {
          "text": "TOTAL",
          "bbox": [
            277.0,
            1391.0,
            424.0,
            1436.0
          ],
          "confidence": 0.9997556805610657
        },
        {
          "text": "S",
          "bbox": [
            2217.0,
            1394.0,
            2249.0,
            1444.0
          ],
          "confidence": 0.644670844078064
        },
        {
          "text": "Less Paid and Un-Recouped Minimum Guarantee:.",
          "bbox": [
            281.0,
            1515.0,
            1200.0,
            1551.0
          ],
          "confidence": 0.9830753803253174
        },
        {
          "text": "$",
          "bbox": [
            2217.0,
            1509.0,
            2248.0,
            1555.0
          ],
          "confidence": 0.9946321249008179
        },
        {
          "text": "([D",
          "bbox": [
            2534.0,
            1509.0,
            2612.0,
            1562.0
          ],
          "confidence": 0.6601287126541138
        },
        {
          "text": "Balance Due From the Company and Payable This Quarter:.",
          "bbox": [
            281.0,
            1624.0,
            1367.0,
            1667.0
          ],
          "confidence": 0.9885050058364868
        },
        {
          "text": "$",
          "bbox": [
            2217.0,
            1626.0,
            2248.0,
            1670.0
          ],
          "confidence": 0.9972478747367859
        },
        {
          "text": "I hereby certify that the above is accurate and complete..",
          "bbox": [
            446.0,
            1745.0,
            1486.0,
            1787.0
          ],
          "confidence": 0.9839082956314087
        },
        {
          "text": "Signature",
          "bbox": [
            556.0,
            1915.0,
            734.0,
            1959.0
          ],
          "confidence": 0.9999518990516663
        },
        {
          "text": "Date",
          "bbox": [
            2060.0,
            1913.0,
            2157.0,
            1958.0
          ],
          "confidence": 0.9998319149017334
        },
        {
          "text": "Title",
          "bbox": [
            548.0,
            2022.0,
            641.0,
            2077.0
          ],
          "confidence": 0.9996421933174133
        },
        {
          "text": "Printed Name",
          "bbox": [
            554.0,
            2141.0,
            803.0,
            2189.0
          ],
          "confidence": 0.9998235702514648
        },
        {
          "text": "Submit to:",
          "bbox": [
            275.0,
            2255.0,
            468.0,
            2303.0
          ],
          "confidence": 0.9777308702468872
        },
        {
          "text": "Name:",
          "bbox": [
            271.0,
            2368.0,
            396.0,
            2413.0
          ],
          "confidence": 0.9997938871383667
        },
        {
          "text": "Email:",
          "bbox": [
            276.0,
            2425.0,
            392.0,
            2471.0
          ],
          "confidence": 0.9990415573120117
        },
        {
          "text": "Tel:",
          "bbox": [
            274.0,
            2485.0,
            348.0,
            2529.0
          ],
          "confidence": 0.9999179840087891
        },
        {
          "text": "Date Received:",
          "bbox": [
            277.0,
            2547.0,
            556.0,
            2586.0
          ],
          "confidence": 0.9998378157615662
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9971140027046204
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "TOTAL",
          "page": 28,
          "bbox": [
            277.0,
            1391.0,
            424.0,
            1436.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_29_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Guaranteed Minimum Royalty during the Second Additional Term:   In the event that the Second Renewal Threshold is achieved in the Sixth Contract Year, during the Second Additional Term the Minimum Royalty and Timing of Payment shall be as follows:   Contract Year   Minimum Royalty   Timing of Payment Seven   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2019; October 1, 2019; February 1, 2020 Eight   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2020; October 1, 2020; February 1, 2021 Nine   $5,000,000   $1,666,666.66 payment due on the following dates: July 23, 2021; October 1, 2021; February 1, 2022",
      "page_number": 29,
      "words": [
        {
          "text": "Exhibit\"C'",
          "bbox": [
            1539.0,
            422.0,
            1766.0,
            464.0
          ],
          "confidence": 0.9423649907112122
        },
        {
          "text": "Section (1)",
          "bbox": [
            442.0,
            533.0,
            656.0,
            581.0
          ],
          "confidence": 0.9598045945167542
        },
        {
          "text": "Guaranteed Minimum Royalty during the initial Term:",
          "bbox": [
            448.0,
            651.0,
            1432.0,
            693.0
          ],
          "confidence": 0.9998934864997864
        },
        {
          "text": "Contract Year",
          "bbox": [
            448.0,
            762.0,
            698.0,
            800.0
          ],
          "confidence": 0.9906719923019409
        },
        {
          "text": "Minimum Royalty",
          "bbox": [
            843.0,
            760.0,
            1175.0,
            804.0
          ],
          "confidence": 0.9979216456413269
        },
        {
          "text": "Timing of Payment",
          "bbox": [
            1430.0,
            764.0,
            1776.0,
            802.0
          ],
          "confidence": 0.9999237060546875
        },
        {
          "text": "One",
          "bbox": [
            442.0,
            822.0,
            528.0,
            869.0
          ],
          "confidence": 0.9998375773429871
        },
        {
          "text": "$1,500,000",
          "bbox": [
            845.0,
            824.0,
            1037.0,
            868.0
          ],
          "confidence": 0.9999626874923706
        },
        {
          "text": "$500,000 payment due on the following dates: July 23, 2013; October 1,",
          "bbox": [
            1426.0,
            826.0,
            2740.0,
            868.0
          ],
          "confidence": 0.9969886541366577
        },
        {
          "text": "2013; February 1, 2014",
          "bbox": [
            1428.0,
            881.0,
            1842.0,
            921.0
          ],
          "confidence": 0.997204065322876
        },
        {
          "text": "Two",
          "bbox": [
            438.0,
            933.0,
            530.0,
            980.0
          ],
          "confidence": 0.9986575245857239
        },
        {
          "text": "$2,000,000",
          "bbox": [
            845.0,
            936.0,
            1037.0,
            979.0
          ],
          "confidence": 0.9998959302902222
        },
        {
          "text": "$666,666.66 payment due on the following dates: July 23, 2014; October",
          "bbox": [
            1430.0,
            941.0,
            2750.0,
            978.0
          ],
          "confidence": 0.9964415431022644
        },
        {
          "text": "1, 2014; February 1, 2015",
          "bbox": [
            1426.0,
            990.0,
            1885.0,
            1036.0
          ],
          "confidence": 0.9955172538757324
        },
        {
          "text": "Three",
          "bbox": [
            440.0,
            1047.0,
            558.0,
            1093.0
          ],
          "confidence": 0.9998759031295776
        },
        {
          "text": "$2,500,000",
          "bbox": [
            846.0,
            1047.0,
            1037.0,
            1091.0
          ],
          "confidence": 0.9999494552612305
        },
        {
          "text": "$833,333.33 payment due on the following dates: July 23, 2015; October",
          "bbox": [
            1428.0,
            1051.0,
            2751.0,
            1093.0
          ],
          "confidence": 0.998781681060791
        },
        {
          "text": "1, 2015; February 1, 2016",
          "bbox": [
            1426.0,
            1104.0,
            1885.0,
            1149.0
          ],
          "confidence": 0.9957472085952759
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973068237304688
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Endorser shall also supply MusclePharm with at least fifty (50) signed items for each Contract Year, on the Licensed Products or on other items to be mutually agreed upon by the parties hereto, to be used by MusclePharm in connection with the promotion of the Products and/or Licensed Products.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Endorser shall also supply MusclePharm with at least fifty (50) signed items for each Contract Year, on the Licensed Products or on other items to be mutually agreed upon by the parties hereto, to be used by MusclePharm in connection with the promotion of the Products and/or Licensed Products.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Minimum Commitment_29_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Guaranteed Minimum Royalty during the initial Term:   Contract Year   Minimum Royalty   Timing of Payment One   $1,500,000   $500,000 payment due on the following dates: July 23, 2013; October 1, 2013; February 1, 2014 Two   $2,000,000   $666,666.66 payment due on the following dates: July 23, 2014; October 1, 2014; February 1, 2015 Three   $2,500,000   $833,333.33 payment due on the following dates: July 23, 2015; October 1, 2015; February 1, 2016",
      "page_number": 29,
      "words": [
        {
          "text": "Guaranteed Minimum Royalty during the initial Term:",
          "bbox": [
            448.0,
            651.0,
            1432.0,
            693.0
          ],
          "confidence": 0.9998934864997864
        },
        {
          "text": "Contract Year",
          "bbox": [
            448.0,
            762.0,
            698.0,
            800.0
          ],
          "confidence": 0.9906719923019409
        },
        {
          "text": "Minimum Royalty",
          "bbox": [
            843.0,
            760.0,
            1175.0,
            804.0
          ],
          "confidence": 0.9979216456413269
        },
        {
          "text": "Timing of Payment",
          "bbox": [
            1430.0,
            764.0,
            1776.0,
            802.0
          ],
          "confidence": 0.9999237060546875
        },
        {
          "text": "One",
          "bbox": [
            442.0,
            822.0,
            528.0,
            869.0
          ],
          "confidence": 0.9998375773429871
        },
        {
          "text": "$1,500,000",
          "bbox": [
            845.0,
            824.0,
            1037.0,
            868.0
          ],
          "confidence": 0.9999626874923706
        },
        {
          "text": "$500,000 payment due on the following dates: July 23, 2013; October 1,",
          "bbox": [
            1426.0,
            826.0,
            2740.0,
            868.0
          ],
          "confidence": 0.9969886541366577
        },
        {
          "text": "2013; February 1, 2014",
          "bbox": [
            1428.0,
            881.0,
            1842.0,
            921.0
          ],
          "confidence": 0.997204065322876
        },
        {
          "text": "Two",
          "bbox": [
            438.0,
            933.0,
            530.0,
            980.0
          ],
          "confidence": 0.9986575245857239
        },
        {
          "text": "$2,000,000",
          "bbox": [
            845.0,
            936.0,
            1037.0,
            979.0
          ],
          "confidence": 0.9998959302902222
        },
        {
          "text": "$666,666.66 payment due on the following dates: July 23, 2014; October",
          "bbox": [
            1430.0,
            941.0,
            2750.0,
            978.0
          ],
          "confidence": 0.9964415431022644
        },
        {
          "text": "1, 2014; February 1, 2015",
          "bbox": [
            1426.0,
            990.0,
            1885.0,
            1036.0
          ],
          "confidence": 0.9955172538757324
        },
        {
          "text": "Three",
          "bbox": [
            440.0,
            1047.0,
            558.0,
            1093.0
          ],
          "confidence": 0.9998759031295776
        },
        {
          "text": "$2,500,000",
          "bbox": [
            846.0,
            1047.0,
            1037.0,
            1091.0
          ],
          "confidence": 0.9999494552612305
        },
        {
          "text": "$833,333.33 payment due on the following dates: July 23, 2015; October",
          "bbox": [
            1428.0,
            1051.0,
            2751.0,
            1093.0
          ],
          "confidence": 0.998781681060791
        },
        {
          "text": "1, 2015; February 1, 2016",
          "bbox": [
            1426.0,
            1104.0,
            1885.0,
            1149.0
          ],
          "confidence": 0.9957472085952759
        }
      ],
      "multi_page": true,
      "part_of": 1
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Volume Restriction_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Volume Restriction\" that should be reviewed by a lawyer. Details: Is there a fee increase or consent requirement, etc. if one party’s use of the product/services exceeds certain threshold?",
      "answer_text": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Volume Restriction_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Volume Restriction\" that should be reviewed by a lawyer. Details: Is there a fee increase or consent requirement, etc. if one party’s use of the product/services exceeds certain threshold?",
      "answer_text": "During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual sample of such new Product (the \"Sample\") and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written agreement of the parties hereto.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Ip Ownership Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "MusclePharm agrees that any copyrights in works created based upon the Trademarks and/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Ip Ownership Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "MusclePharm agrees that any copyrights in works created based upon the Trademarks and/or Name and Appearance Rights shall become the rights of the AS Parties (as among them to be determined among them)",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Ip Ownership Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "All such works based upon the Trademarks and/or Name and Appearance Rights shall be prepared by an employee-for- hire of MusclePharm (under MusclePharms's sole supervision, responsibility, and monetary obligation) or as a work-for-hire by a third party who assigns to the AS Parties in writing and in perpetuity throughout the universe all right, title, and interest in the same provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Ip Ownership Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "All such works based upon the Trademarks and/or Name and Appearance Rights shall be prepared by an employee-for- hire of MusclePharm (under MusclePharms's sole supervision, responsibility, and monetary obligation) or as a work-for-hire by a third party who assigns to the AS Parties in writing and in perpetuity throughout the universe all right, title, and interest in the same provided however, nothing herein shall preclude MusclePharm from using any of the intellectual property to be retained by MusclePharm contemplated pursuant to Section 9(f) of this Agreement after the termination of this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Ip Ownership Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "MusclePharm irrevocably and unconditionally transfers and assigns to the AS Parties in perpetuity and throughout the universe any and all of MusclePharm's right, title, and interest, if any (including, without limitation, the rights generally known as 'moral rights') in and to all works, including any packaging, advertising and promotional materials, and other materials based upon the Trademarks and/or Name and Appearance Rights, all of which shall, upon their creation, become and remain the property of the AS Parties.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Ip Ownership Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Ip Ownership Assignment\" that should be reviewed by a lawyer. Details: Does intellectual property created  by one party become the property of the counterparty, either per the terms of the contract or upon the occurrence of certain events?",
      "answer_text": "MusclePharm irrevocably and unconditionally transfers and assigns to the AS Parties in perpetuity and throughout the universe any and all of MusclePharm's right, title, and interest, if any (including, without limitation, the rights generally known as 'moral rights') in and to all works, including any packaging, advertising and promotional materials, and other materials based upon the Trademarks and/or Name and Appearance Rights, all of which shall, upon their creation, become and remain the property of the AS Parties.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "During the Term of this Agreement, the AS Parties grant to MusclePharm and consent to MusclePharm's commercial use of the Name and Appearance Rights to advertise, promote, endorse and publicize Products, Licensed Products, and MusclePharm's business, worldwide in any media selected by MusclePharm (excluding telephone or texting campaigns), including but not limited to print, radio, television, electronic, wireless or internet, pursuant to the terms and conditions set forth herein. MusclePharm acknowledges that any use on products requires approval and that use of the Name and Appearance Rights on products is limited to the Licensed Products.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "During the Term of this Agreement, the AS Parties grant to MusclePharm and consent to MusclePharm's commercial use of the Name and Appearance Rights to advertise, promote, endorse and publicize Products, Licensed Products, and MusclePharm's business, worldwide in any media selected by MusclePharm (excluding telephone or texting campaigns), including but not limited to print, radio, television, electronic, wireless or internet, pursuant to the terms and conditions set forth herein. MusclePharm acknowledges that any use on products requires approval and that use of the Name and Appearance Rights on products is limited to the Licensed Products.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Endorser agrees that during the Term MusclePharm shall have the right to use, worldwide, Endorser's Name and Appearance Rights (as specified in Section 6) to advertise MusclePharm and its Products and Licensed Products in print media, and in all other forms of media (other than telephone marketing or texting campaigns) including, but not limited to, point of sale material, premiums and novelties, direct marketing material, and radio, television, electronic, and computer media (including but not limited to MusclePharm's Internet and social media websites). Print media will also include promotional items on which Endorser's approved picture; approved likeness, or facsimile signature may appear. Endorser will have the right to approve, in writing via his representative's office, all advertising materials which utilize Endorser's Name and Appearance Rights, but Endorser will not unreasonably withhold approval and will promptly respond to all approval requests.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Endorser agrees that during the Term MusclePharm shall have the right to use, worldwide, Endorser's Name and Appearance Rights (as specified in Section 6) to advertise MusclePharm and its Products and Licensed Products in print media, and in all other forms of media (other than telephone marketing or texting campaigns) including, but not limited to, point of sale material, premiums and novelties, direct marketing material, and radio, television, electronic, and computer media (including but not limited to MusclePharm's Internet and social media websites). Print media will also include promotional items on which Endorser's approved picture; approved likeness, or facsimile signature may appear. Endorser will have the right to approve, in writing via his representative's office, all advertising materials which utilize Endorser's Name and Appearance Rights, but Endorser will not unreasonably withhold approval and will promptly respond to all approval requests.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "During the Term, MusclePharm shall have the right to create and distribute the Promotional Products world- wide.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Endorser also grants to MusclePharm and consents to MusclePharm's editorial use world-wide of Endorser's Name and Appearance in MusclePharm published materials approved by Endorser. For purposes of this Agreement, MusclePharm's editorial use of Endorser's Name and Appearance shall mean a use that does not directly promote, advertise or endorse MusclePharm's business, its Products or Licensed Products. Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any).",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Endorser also grants to MusclePharm and consents to MusclePharm's editorial use world-wide of Endorser's Name and Appearance in MusclePharm published materials approved by Endorser. For purposes of this Agreement, MusclePharm's editorial use of Endorser's Name and Appearance shall mean a use that does not directly promote, advertise or endorse MusclePharm's business, its Products or Licensed Products. Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any).",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "MusclePharm shall have the rights to use Endorser's Name and Appearance Rights and the Right to Publicize Endorser's Name and Appearance, as provided in this Agreement, unless Endorser and MusclePharm enter into a separate written agreement in which MusclePharm waives or releases some or all of the rights Endorser has granted in this Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "MusclePharm shall have the rights to use Endorser's Name and Appearance Rights and the Right to Publicize Endorser's Name and Appearance, as provided in this Agreement, unless Endorser and MusclePharm enter into a separate written agreement in which MusclePharm waives or releases some or all of the rights Endorser has granted in this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of MusclePharm, its Products, and the Licensed Products.",
      "page_number": 1,
      "words": [
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        }
      ],
      "multi_page": true,
      "part_of": 1,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "As provided below, during the Term, the AS Parties grant to MusclePharm the right to use the Trademarks as defined in this Agreement and the Name and Appearance Rights, which shall include Endorser's name, approved photograph, approved picture (including, without limitation, any copyrighted pictures and video images of the Endorser owned by the Endorser which Endorser agrees to make available for use hereunder), approved appearance, or approved likeness, including video and other recordings of Endorser's appearance, along with the right to use Endorser's voice, including audio or other recordings of Endorser's voice, Endorser's signature, personal or professional background and experience, reputation, approved quotations and approved endorsements, or approved paraphrases of Endorser's approved quotations and endorsements, including approved touch-ups, approved simulations or approved compositions of any of the above whether generated by computer or by any other means, for the period of time and for the purposes set forth in this Agreement. MusclePharm acknowledges that the use of some works may require that MusclePharm obtain a copyright license from third parties.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "As provided below, during the Term, the AS Parties grant to MusclePharm the right to use the Trademarks as defined in this Agreement and the Name and Appearance Rights, which shall include Endorser's name, approved photograph, approved picture (including, without limitation, any copyrighted pictures and video images of the Endorser owned by the Endorser which Endorser agrees to make available for use hereunder), approved appearance, or approved likeness, including video and other recordings of Endorser's appearance, along with the right to use Endorser's voice, including audio or other recordings of Endorser's voice, Endorser's signature, personal or professional background and experience, reputation, approved quotations and approved endorsements, or approved paraphrases of Endorser's approved quotations and endorsements, including approved touch-ups, approved simulations or approved compositions of any of the above whether generated by computer or by any other means, for the period of time and for the purposes set forth in this Agreement. MusclePharm acknowledges that the use of some works may require that MusclePharm obtain a copyright license from third parties.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "During the Term, the right to use Endorser's Name and Appearance Rights granted to MusclePharm in this Section shall extend for six (6) months beyond the expiration of this Agreement (the \"Use-up Period\").",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "During the Term, the right to use Endorser's Name and Appearance Rights granted to MusclePharm in this Section shall extend for six (6) months beyond the expiration of this Agreement (the \"Use-up Period\").",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "MusclePharm shall create no new advertising during the Use-up Period using Endorser's Name and Appearance, but shall have the right to use during the Use-up Period Endorser's Name and Appearance in advertisements and promotional materials created before the expiration date of this Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "MusclePharm shall create no new advertising during the Use-up Period using Endorser's Name and Appearance, but shall have the right to use during the Use-up Period Endorser's Name and Appearance in advertisements and promotional materials created before the expiration date of this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "MusclePharm agrees to preserve and keep accessible and available to the AS Parties all relevant books and records for a period of at least three (3) years following the expiration or termination of the Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "MusclePharm agrees to preserve and keep accessible and available to the AS Parties all relevant books and records for a period of at least three (3) years following the expiration or termination of the Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "Notwithstanding the foregoing, in the event the expiration of this Agreement or termination of this Agreement by Musclepharm pursuant to paragraph 9(a), MusclePharm shall be entitled to sell-off the remaining Licensed Products for six (6) months after such expiration of this Agreement pursuant to paragraph 4(d) herein and shall continue to pay Endorser the Royalty set forth in paragraph 7 herein.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "During the Term of this Agreement and during any sell-off period, MusclePharm shall pay Lender a royalty (the \"Royalty\") of 10% on Net Sales (as defined below) of Licensed Products sold through its wholesale Distribution Channels or retail Distribution Channels, as the case may be and 10% on Net Sales of the Training Video and any Products sold in connection with any Training Video as contemplated pursuant to the last sentence of Section 4(a)(i) above.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "MusclePharm's obligations for the payment of a Royalty and the Guaranteed Minimum Royalty (as defined below) shall survive expiration or termination of this Agreement and will continue for so long as MusclePharm continues to manufacture, sell or otherwise market the Licensed Products.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "MusclePharm's obligations for the payment of a Royalty and the Guaranteed Minimum Royalty (as defined below) shall survive expiration or termination of this Agreement and will continue for so long as MusclePharm continues to manufacture, sell or otherwise market the Licensed Products.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense, randomly test the formulas of the Licensed Products for quality control purposes, although the AS Parties will have no obligation to do so.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "MusclePharm shall at all reasonable times during the Term (but no more than once during each Contract Year of the Term), and upon reasonable notice, permit the AS Parties to send their authorized representatives to inspect the facilities of MusclePharm or its agents in order to confirm that the production of the Licensed Products hereunder is in compliance with the quality standards set out herein and, at MusclePharm's expense, randomly test the formulas of the Licensed Products for quality control purposes, although the AS Parties will have no obligation to do so.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "In the event a shortfall in the amount of five percent (5%) or more is discovered, MusclePharm shall reimburse the AS Parties for the cost of the audit including any reasonable attorney's fees incurred in connection therewith.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "In the event a shortfall in the amount of five percent (5%) or more is discovered, MusclePharm shall reimburse the AS Parties for the cost of the audit including any reasonable attorney's fees incurred in connection therewith.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "Lender understands that all books, records, and documents of MusclePharm relating to it have been and remain available for inspection by him or his business and financial advisors upon reasonable notice.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "Lender understands that all books, records, and documents of MusclePharm relating to it have been and remain available for inspection by him or his business and financial advisors upon reasonable notice.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Audit Rights_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Cap On Liability_2",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "In no event shall the AS Parties' indemnification obligations to MusclePharm hereunder exceed the after-tax value of the Cash Consideration received by Lender under this Agreement.",
      "page_number": 2,
      "words": [
        {
          "text": "(b) Products. As used in this Agreement, \"Products\" shall mean dietary supplements manufactured within the fifty states of the United",
          "bbox": [
            448.0,
            426.0,
            3029.0,
            468.0
          ],
          "confidence": 0.9876304864883423
        },
        {
          "text": "States of America; provided, however, MusclePharm shall not produce during the Term (and any renewal Term, if any) any diet pills and/or sexual",
          "bbox": [
            279.0,
            482.0,
            3029.0,
            524.0
          ],
          "confidence": 0.994454026222229
        },
        {
          "text": "enhancement products; provided, further, that fat burning products, Shred Matrix and Live Shredded products and products that increase",
          "bbox": [
            281.0,
            539.0,
            3029.0,
            581.0
          ],
          "confidence": 0.9972802996635437
        },
        {
          "text": "testosterone levels currently produced by MusclePharm as of the date hereof shall be part of the definition of Products for the purpose of this.",
          "bbox": [
            275.0,
            592.0,
            3027.0,
            638.0
          ],
          "confidence": 0.9937463402748108
        },
        {
          "text": "Agreement.",
          "bbox": [
            279.0,
            651.0,
            495.0,
            694.0
          ],
          "confidence": 0.9572042226791382
        },
        {
          "text": "(c) New Products. During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and",
          "bbox": [
            448.0,
            762.0,
            3029.0,
            804.0
          ],
          "confidence": 0.9988813400268555
        },
        {
          "text": "introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual.",
          "bbox": [
            277.0,
            819.0,
            3027.0,
            859.0
          ],
          "confidence": 0.9903531074523926
        },
        {
          "text": "sample of such new Product (the \"Sample') and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm",
          "bbox": [
            275.0,
            873.0,
            3029.0,
            917.0
          ],
          "confidence": 0.9890959858894348
        },
        {
          "text": "within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no",
          "bbox": [
            281.0,
            934.0,
            3027.0,
            970.0
          ],
          "confidence": 0.9913779497146606
        },
        {
          "text": "less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written",
          "bbox": [
            276.0,
            985.0,
            3029.0,
            1027.0
          ],
          "confidence": 0.9907599091529846
        },
        {
          "text": "agreement of the parties hereto.",
          "bbox": [
            279.0,
            1045.0,
            866.0,
            1085.0
          ],
          "confidence": 0.9954173564910889
        },
        {
          "text": "(d) Distribution Channels - Licensed Products. Subject to the terms and conditions herein (including the Exhibits), the license to",
          "bbox": [
            448.0,
            1155.0,
            3027.0,
            1197.0
          ],
          "confidence": 0.9957139492034912
        },
        {
          "text": "MusclePharm with respect to distribution and promotion of the Licensed Products is on a worldwide basis through the Distribution Channels (as",
          "bbox": [
            277.0,
            1212.0,
            3027.0,
            1254.0
          ],
          "confidence": 0.9994755983352661
        },
        {
          "text": "defined below) subject to approval rights set forth in Section 13 herein. For the purposes of this Agreement, \"Distribution Channels\"' means the",
          "bbox": [
            279.0,
            1268.0,
            3027.0,
            1310.0
          ],
          "confidence": 0.9890642166137695
        },
        {
          "text": "distribution of the Licensed Products through GNC retail and online chains worldwide during the First Contract Year and, thereafter, through",
          "bbox": [
            277.0,
            1321.0,
            3025.0,
            1367.0
          ],
          "confidence": 0.988422691822052
        },
        {
          "text": "MusclePharm's other worldwide distribution channels, as mutually determined by MusclePharm and the AS Parties.",
          "bbox": [
            277.0,
            1380.0,
            2431.0,
            1422.0
          ],
          "confidence": 0.9945962429046631
        },
        {
          "text": "3. Endorsement of Products:",
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ],
          "confidence": 0.9750658869743347
        },
        {
          "text": "Endorser agrees that he will use and evaluate the Products and Licensed Products according to the recommended use and dose",
          "bbox": [
            446.0,
            1606.0,
            3027.0,
            1650.0
          ],
          "confidence": 0.9927414059638977
        },
        {
          "text": "guidelines. Based on Endorser's knowledge, personal use and experience with the Products and Licensed Products that he shall from time to time",
          "bbox": [
            279.0,
            1661.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9863718748092651
        },
        {
          "text": "during the Term of this Agreement provide his honest evaluation, opinion, and findings about the Products and Licensed Products he is endorsing",
          "bbox": [
            277.0,
            1718.0,
            3027.0,
            1763.0
          ],
          "confidence": 0.992676854133606
        },
        {
          "text": "and promoting. The endorsements must be based on Endorser's knowledge and/or personal use and experience with the Products and Licensed",
          "bbox": [
            279.0,
            1776.0,
            3029.0,
            1818.0
          ],
          "confidence": 0.995076060295105
        },
        {
          "text": "Products at or about the times the endorsements are made. Endorser's statements and endorsements, or paraphrases thereof, may be used by",
          "bbox": [
            275.0,
            1829.0,
            3025.0,
            1875.0
          ],
          "confidence": 0.991610586643219
        },
        {
          "text": "MusclePharm to advertise, promote and publicize its business, Products and Licensed Products as provided herein. Endorser's endorsements of.",
          "bbox": [
            275.0,
            1886.0,
            3032.0,
            1932.0
          ],
          "confidence": 0.9898184537887573
        },
        {
          "text": "the Products and Licensed Products will be in accordance with the guidelines established by the Federal Trade Commission for endorsements in.",
          "bbox": [
            279.0,
            1944.0,
            3027.0,
            1985.0
          ],
          "confidence": 0.9928502440452576
        },
        {
          "text": "advertising. If requested by MusclePharm, Endorser shall provide a signed affidavit in form satisfactory to MusclePharm confirming Endorser's",
          "bbox": [
            277.0,
            1999.0,
            3029.0,
            2043.0
          ],
          "confidence": 0.9966766238212585
        },
        {
          "text": "compliance with the FTC standards in connection with his endorsements and endorsement activities..",
          "bbox": [
            281.0,
            2058.0,
            2155.0,
            2100.0
          ],
          "confidence": 0.9970789551734924
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9981697797775269
        }
      ],
      "nearby_headers": [
        {
          "text": "3. Endorsement of Products:",
          "page": 2,
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Cap On Liability_1",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "IN NO EVENT SHALL THE AS PARTIES BE LIABLE FOR SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability, in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability, in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "Without limiting the generality of the foregoing, such policy shall provide protection against any and all claims, demands, and causes of action arising out of any defects or failure to perform, alleged or otherwise, of the Products and Licensed Products or any material used in connection therewith or any use thereof.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "Without limiting the generality of the foregoing, such policy shall provide protection against any and all claims, demands, and causes of action arising out of any defects or failure to perform, alleged or otherwise, of the Products and Licensed Products or any material used in connection therewith or any use thereof.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "The policy shall provide for ten (10) days notice to the AS Parties from the insurer by Registered or Certified Mail, return receipt requested, in the event of any modification, cancellation, or termination thereof.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_2_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "The policy shall provide for ten (10) days notice to the AS Parties from the insurer by Registered or Certified Mail, return receipt requested, in the event of any modification, cancellation, or termination thereof.",
      "page_number": 2,
      "words": [
        {
          "text": "(b) Products. As used in this Agreement, \"Products\" shall mean dietary supplements manufactured within the fifty states of the United",
          "bbox": [
            448.0,
            426.0,
            3029.0,
            468.0
          ],
          "confidence": 0.9876304864883423
        },
        {
          "text": "States of America; provided, however, MusclePharm shall not produce during the Term (and any renewal Term, if any) any diet pills and/or sexual",
          "bbox": [
            279.0,
            482.0,
            3029.0,
            524.0
          ],
          "confidence": 0.994454026222229
        },
        {
          "text": "enhancement products; provided, further, that fat burning products, Shred Matrix and Live Shredded products and products that increase",
          "bbox": [
            281.0,
            539.0,
            3029.0,
            581.0
          ],
          "confidence": 0.9972802996635437
        },
        {
          "text": "testosterone levels currently produced by MusclePharm as of the date hereof shall be part of the definition of Products for the purpose of this.",
          "bbox": [
            275.0,
            592.0,
            3027.0,
            638.0
          ],
          "confidence": 0.9937463402748108
        },
        {
          "text": "Agreement.",
          "bbox": [
            279.0,
            651.0,
            495.0,
            694.0
          ],
          "confidence": 0.9572042226791382
        },
        {
          "text": "(c) New Products. During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and",
          "bbox": [
            448.0,
            762.0,
            3029.0,
            804.0
          ],
          "confidence": 0.9988813400268555
        },
        {
          "text": "introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual.",
          "bbox": [
            277.0,
            819.0,
            3027.0,
            859.0
          ],
          "confidence": 0.9903531074523926
        },
        {
          "text": "sample of such new Product (the \"Sample') and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm",
          "bbox": [
            275.0,
            873.0,
            3029.0,
            917.0
          ],
          "confidence": 0.9890959858894348
        },
        {
          "text": "within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no",
          "bbox": [
            281.0,
            934.0,
            3027.0,
            970.0
          ],
          "confidence": 0.9913779497146606
        },
        {
          "text": "less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written",
          "bbox": [
            276.0,
            985.0,
            3029.0,
            1027.0
          ],
          "confidence": 0.9907599091529846
        },
        {
          "text": "agreement of the parties hereto.",
          "bbox": [
            279.0,
            1045.0,
            866.0,
            1085.0
          ],
          "confidence": 0.9954173564910889
        },
        {
          "text": "(d) Distribution Channels - Licensed Products. Subject to the terms and conditions herein (including the Exhibits), the license to",
          "bbox": [
            448.0,
            1155.0,
            3027.0,
            1197.0
          ],
          "confidence": 0.9957139492034912
        },
        {
          "text": "MusclePharm with respect to distribution and promotion of the Licensed Products is on a worldwide basis through the Distribution Channels (as",
          "bbox": [
            277.0,
            1212.0,
            3027.0,
            1254.0
          ],
          "confidence": 0.9994755983352661
        },
        {
          "text": "defined below) subject to approval rights set forth in Section 13 herein. For the purposes of this Agreement, \"Distribution Channels\"' means the",
          "bbox": [
            279.0,
            1268.0,
            3027.0,
            1310.0
          ],
          "confidence": 0.9890642166137695
        },
        {
          "text": "distribution of the Licensed Products through GNC retail and online chains worldwide during the First Contract Year and, thereafter, through",
          "bbox": [
            277.0,
            1321.0,
            3025.0,
            1367.0
          ],
          "confidence": 0.988422691822052
        },
        {
          "text": "MusclePharm's other worldwide distribution channels, as mutually determined by MusclePharm and the AS Parties.",
          "bbox": [
            277.0,
            1380.0,
            2431.0,
            1422.0
          ],
          "confidence": 0.9945962429046631
        },
        {
          "text": "3. Endorsement of Products:",
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ],
          "confidence": 0.9750658869743347
        },
        {
          "text": "Endorser agrees that he will use and evaluate the Products and Licensed Products according to the recommended use and dose",
          "bbox": [
            446.0,
            1606.0,
            3027.0,
            1650.0
          ],
          "confidence": 0.9927414059638977
        },
        {
          "text": "guidelines. Based on Endorser's knowledge, personal use and experience with the Products and Licensed Products that he shall from time to time",
          "bbox": [
            279.0,
            1661.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9863718748092651
        },
        {
          "text": "during the Term of this Agreement provide his honest evaluation, opinion, and findings about the Products and Licensed Products he is endorsing",
          "bbox": [
            277.0,
            1718.0,
            3027.0,
            1763.0
          ],
          "confidence": 0.992676854133606
        },
        {
          "text": "and promoting. The endorsements must be based on Endorser's knowledge and/or personal use and experience with the Products and Licensed",
          "bbox": [
            279.0,
            1776.0,
            3029.0,
            1818.0
          ],
          "confidence": 0.995076060295105
        },
        {
          "text": "Products at or about the times the endorsements are made. Endorser's statements and endorsements, or paraphrases thereof, may be used by",
          "bbox": [
            275.0,
            1829.0,
            3025.0,
            1875.0
          ],
          "confidence": 0.991610586643219
        },
        {
          "text": "MusclePharm to advertise, promote and publicize its business, Products and Licensed Products as provided herein. Endorser's endorsements of.",
          "bbox": [
            275.0,
            1886.0,
            3032.0,
            1932.0
          ],
          "confidence": 0.9898184537887573
        },
        {
          "text": "the Products and Licensed Products will be in accordance with the guidelines established by the Federal Trade Commission for endorsements in.",
          "bbox": [
            279.0,
            1944.0,
            3027.0,
            1985.0
          ],
          "confidence": 0.9928502440452576
        },
        {
          "text": "advertising. If requested by MusclePharm, Endorser shall provide a signed affidavit in form satisfactory to MusclePharm confirming Endorser's",
          "bbox": [
            277.0,
            1999.0,
            3029.0,
            2043.0
          ],
          "confidence": 0.9966766238212585
        },
        {
          "text": "compliance with the FTC standards in connection with his endorsements and endorsement activities..",
          "bbox": [
            281.0,
            2058.0,
            2155.0,
            2100.0
          ],
          "confidence": 0.9970789551734924
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9981697797775269
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "3. Endorsement of Products:",
          "page": 2,
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm shall be responsible to provide for any appearances pursuant to this Agreement by Endorser appropriate certificates of insurance with coverage limits of at least Five Million Dollars (US$5,000,000) per occurrence endorsed to name the AS Parties as additional named insureds with respect to claims arising out of appearances by Endorser.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm agrees to furnish the AS Parties a certificate of insurance evidencing same within thirty (30) days after execution of this Agreement and, in no event, shall MusclePharm manufacture, distribute, advertise, or sell the Licensed Products prior to receipt by the AS Parties of such evidence of insurance.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm agrees to furnish the AS Parties a certificate of insurance evidencing same within thirty (30) days after execution of this Agreement and, in no event, shall MusclePharm manufacture, distribute, advertise, or sell the Licensed Products prior to receipt by the AS Parties of such evidence of insurance.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Insurance_2",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "MusclePharm shall be responsible to pay the deductible under any such insurance policies with respect to any claims made under such policies.",
      "page_number": 2,
      "words": [
        {
          "text": "(b) Products. As used in this Agreement, \"Products\" shall mean dietary supplements manufactured within the fifty states of the United",
          "bbox": [
            448.0,
            426.0,
            3029.0,
            468.0
          ],
          "confidence": 0.9876304864883423
        },
        {
          "text": "States of America; provided, however, MusclePharm shall not produce during the Term (and any renewal Term, if any) any diet pills and/or sexual",
          "bbox": [
            279.0,
            482.0,
            3029.0,
            524.0
          ],
          "confidence": 0.994454026222229
        },
        {
          "text": "enhancement products; provided, further, that fat burning products, Shred Matrix and Live Shredded products and products that increase",
          "bbox": [
            281.0,
            539.0,
            3029.0,
            581.0
          ],
          "confidence": 0.9972802996635437
        },
        {
          "text": "testosterone levels currently produced by MusclePharm as of the date hereof shall be part of the definition of Products for the purpose of this.",
          "bbox": [
            275.0,
            592.0,
            3027.0,
            638.0
          ],
          "confidence": 0.9937463402748108
        },
        {
          "text": "Agreement.",
          "bbox": [
            279.0,
            651.0,
            495.0,
            694.0
          ],
          "confidence": 0.9572042226791382
        },
        {
          "text": "(c) New Products. During the Term (including any renewal Term, if any), in the event that MusclePharm shall determine to develop and",
          "bbox": [
            448.0,
            762.0,
            3029.0,
            804.0
          ],
          "confidence": 0.9988813400268555
        },
        {
          "text": "introduce a new Product into the market, MusclePharm shall provide the AS Parties with a sample of the name, design, marketing plan and an actual.",
          "bbox": [
            277.0,
            819.0,
            3027.0,
            859.0
          ],
          "confidence": 0.9903531074523926
        },
        {
          "text": "sample of such new Product (the \"Sample') and the AS Parties shall have a right of first refusal (exercisable by written notice to MusclePharm",
          "bbox": [
            275.0,
            873.0,
            3029.0,
            917.0
          ],
          "confidence": 0.9890959858894348
        },
        {
          "text": "within 15 days after receipt of the Sample) to include such new Product in the AS Product Line, it being understood that there shall initially be no",
          "bbox": [
            281.0,
            934.0,
            3027.0,
            970.0
          ],
          "confidence": 0.9913779497146606
        },
        {
          "text": "less than four (4) Products at the start of the Term and thereafter no more than 8 (eight) Products in the AS Product Line without the mutual written",
          "bbox": [
            276.0,
            985.0,
            3029.0,
            1027.0
          ],
          "confidence": 0.9907599091529846
        },
        {
          "text": "agreement of the parties hereto.",
          "bbox": [
            279.0,
            1045.0,
            866.0,
            1085.0
          ],
          "confidence": 0.9954173564910889
        },
        {
          "text": "(d) Distribution Channels - Licensed Products. Subject to the terms and conditions herein (including the Exhibits), the license to",
          "bbox": [
            448.0,
            1155.0,
            3027.0,
            1197.0
          ],
          "confidence": 0.9957139492034912
        },
        {
          "text": "MusclePharm with respect to distribution and promotion of the Licensed Products is on a worldwide basis through the Distribution Channels (as",
          "bbox": [
            277.0,
            1212.0,
            3027.0,
            1254.0
          ],
          "confidence": 0.9994755983352661
        },
        {
          "text": "defined below) subject to approval rights set forth in Section 13 herein. For the purposes of this Agreement, \"Distribution Channels\"' means the",
          "bbox": [
            279.0,
            1268.0,
            3027.0,
            1310.0
          ],
          "confidence": 0.9890642166137695
        },
        {
          "text": "distribution of the Licensed Products through GNC retail and online chains worldwide during the First Contract Year and, thereafter, through",
          "bbox": [
            277.0,
            1321.0,
            3025.0,
            1367.0
          ],
          "confidence": 0.988422691822052
        },
        {
          "text": "MusclePharm's other worldwide distribution channels, as mutually determined by MusclePharm and the AS Parties.",
          "bbox": [
            277.0,
            1380.0,
            2431.0,
            1422.0
          ],
          "confidence": 0.9945962429046631
        },
        {
          "text": "3. Endorsement of Products:",
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ],
          "confidence": 0.9750658869743347
        },
        {
          "text": "Endorser agrees that he will use and evaluate the Products and Licensed Products according to the recommended use and dose",
          "bbox": [
            446.0,
            1606.0,
            3027.0,
            1650.0
          ],
          "confidence": 0.9927414059638977
        },
        {
          "text": "guidelines. Based on Endorser's knowledge, personal use and experience with the Products and Licensed Products that he shall from time to time",
          "bbox": [
            279.0,
            1661.0,
            3027.0,
            1707.0
          ],
          "confidence": 0.9863718748092651
        },
        {
          "text": "during the Term of this Agreement provide his honest evaluation, opinion, and findings about the Products and Licensed Products he is endorsing",
          "bbox": [
            277.0,
            1718.0,
            3027.0,
            1763.0
          ],
          "confidence": 0.992676854133606
        },
        {
          "text": "and promoting. The endorsements must be based on Endorser's knowledge and/or personal use and experience with the Products and Licensed",
          "bbox": [
            279.0,
            1776.0,
            3029.0,
            1818.0
          ],
          "confidence": 0.995076060295105
        },
        {
          "text": "Products at or about the times the endorsements are made. Endorser's statements and endorsements, or paraphrases thereof, may be used by",
          "bbox": [
            275.0,
            1829.0,
            3025.0,
            1875.0
          ],
          "confidence": 0.991610586643219
        },
        {
          "text": "MusclePharm to advertise, promote and publicize its business, Products and Licensed Products as provided herein. Endorser's endorsements of.",
          "bbox": [
            275.0,
            1886.0,
            3032.0,
            1932.0
          ],
          "confidence": 0.9898184537887573
        },
        {
          "text": "the Products and Licensed Products will be in accordance with the guidelines established by the Federal Trade Commission for endorsements in.",
          "bbox": [
            279.0,
            1944.0,
            3027.0,
            1985.0
          ],
          "confidence": 0.9928502440452576
        },
        {
          "text": "advertising. If requested by MusclePharm, Endorser shall provide a signed affidavit in form satisfactory to MusclePharm confirming Endorser's",
          "bbox": [
            277.0,
            1999.0,
            3029.0,
            2043.0
          ],
          "confidence": 0.9966766238212585
        },
        {
          "text": "compliance with the FTC standards in connection with his endorsements and endorsement activities..",
          "bbox": [
            281.0,
            2058.0,
            2155.0,
            2100.0
          ],
          "confidence": 0.9970789551734924
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4437.0,
            1290.0,
            4479.0
          ],
          "confidence": 0.9981697797775269
        }
      ],
      "nearby_headers": [
        {
          "text": "3. Endorsement of Products:",
          "page": 2,
          "bbox": [
            446.0,
            1491.0,
            988.0,
            1531.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Covenant Not To Sue_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Covenant Not To Sue\" that should be reviewed by a lawyer. Details: Is a party restricted from contesting the validity of the counterparty’s ownership of intellectual property or otherwise bringing a claim against the counterparty for matters unrelated to the contract?",
      "answer_text": "During the Term and after expiration or termination of this Agreement, MusclePharm shall not contest or otherwise challenge or attack the AS Parties' rights in the Trademarks or Name and Appearance Rights or the validity of the license being granted herein.",
      "page_number": 0,
      "words": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ],
          "confidence": 0.9946737885475159
        },
        {
          "text": "This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and",
          "bbox": [
            446.0,
            451.0,
            3029.0,
            495.0
          ],
          "confidence": 0.9884457588195801
        },
        {
          "text": "Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver,",
          "bbox": [
            277.0,
            563.0,
            3029.0,
            610.0
          ],
          "confidence": 0.9852718114852905
        },
        {
          "text": "Colorado and its subsidiaries, (collectively, \"MusclePharm'' or the \"Company')",
          "bbox": [
            279.0,
            623.0,
            1754.0,
            665.0
          ],
          "confidence": 0.9795811176300049
        },
        {
          "text": "RECITALS",
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ],
          "confidence": 0.9990712404251099
        },
        {
          "text": "WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved",
          "bbox": [
            446.0,
            844.0,
            3029.0,
            890.0
          ],
          "confidence": 0.9949395656585693
        },
        {
          "text": "signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and",
          "bbox": [
            277.0,
            905.0,
            3027.0,
            947.0
          ],
          "confidence": 0.9923731684684753
        },
        {
          "text": "the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks'); and.",
          "bbox": [
            275.0,
            958.0,
            2142.0,
            1001.0
          ],
          "confidence": 0.9839043617248535
        },
        {
          "text": "WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness",
          "bbox": [
            450.0,
            1071.0,
            3027.0,
            1113.0
          ],
          "confidence": 0.988927960395813
        },
        {
          "text": "enthusiasts, and",
          "bbox": [
            283.0,
            1129.0,
            587.0,
            1166.0
          ],
          "confidence": 0.9980393648147583
        },
        {
          "text": "WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm",
          "bbox": [
            448.0,
            1237.0,
            3025.0,
            1281.0
          ],
          "confidence": 0.9918398261070251
        },
        {
          "text": "Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and.",
          "bbox": [
            277.0,
            1294.0,
            2113.0,
            1339.0
          ],
          "confidence": 0.9916642904281616
        },
        {
          "text": "WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique",
          "bbox": [
            446.0,
            1405.0,
            3025.0,
            1451.0
          ],
          "confidence": 0.9912573099136353
        },
        {
          "text": "Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to",
          "bbox": [
            279.0,
            1462.0,
            3027.0,
            1508.0
          ],
          "confidence": 0.9937330484390259
        },
        {
          "text": "Section 2(b) below), that will be marketed and advertised under the Endorser's name and likeness, all subject to the Endorser's approval, as",
          "bbox": [
            277.0,
            1519.0,
            3025.0,
            1562.0
          ],
          "confidence": 0.9966701865196228
        },
        {
          "text": "described in Section 12, (the \"AS Product Line'); and.",
          "bbox": [
            279.0,
            1575.0,
            1274.0,
            1615.0
          ],
          "confidence": 0.9746875762939453
        },
        {
          "text": "WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this",
          "bbox": [
            448.0,
            1688.0,
            3027.0,
            1732.0
          ],
          "confidence": 0.9908015727996826
        },
        {
          "text": "Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to",
          "bbox": [
            281.0,
            1745.0,
            3027.0,
            1787.0
          ],
          "confidence": 0.9921627044677734
        },
        {
          "text": "develop the AS Product Line and several related promotional giveaway items that will depict the Endorser's name and likeness solely in",
          "bbox": [
            279.0,
            1802.0,
            3027.0,
            1844.0
          ],
          "confidence": 0.9875801205635071
        },
        {
          "text": "conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set.",
          "bbox": [
            279.0,
            1857.0,
            3027.0,
            1900.0
          ],
          "confidence": 0.9917117953300476
        },
        {
          "text": "forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and.",
          "bbox": [
            277.0,
            1910.0,
            3031.0,
            1955.0
          ],
          "confidence": 0.9919674396514893
        },
        {
          "text": "the AS Product Line are referred to as the \"Licensed Products\")..",
          "bbox": [
            277.0,
            1966.0,
            1472.0,
            2012.0
          ],
          "confidence": 0.9872506856918335
        },
        {
          "text": "NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:.",
          "bbox": [
            442.0,
            2078.0,
            2708.0,
            2123.0
          ],
          "confidence": 0.9830953478813171
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.9973942637443542
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT",
          "page": 0,
          "bbox": [
            1013.0,
            344.0,
            2289.0,
            375.0
          ]
        },
        {
          "text": "RECITALS",
          "page": 0,
          "bbox": [
            1546.0,
            735.0,
            1764.0,
            771.0
          ]
        }
      ]
    },
    {
      "id": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement__Covenant Not To Sue_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Covenant Not To Sue\" that should be reviewed by a lawyer. Details: Is a party restricted from contesting the validity of the counterparty’s ownership of intellectual property or otherwise bringing a claim against the counterparty for matters unrelated to the contract?",
      "answer_text": "During the Term and after expiration or termination of this Agreement, MusclePharm shall not contest or otherwise challenge or attack the AS Parties' rights in the Trademarks or Name and Appearance Rights or the validity of the license being granted herein.",
      "page_number": 1,
      "words": [
        {
          "text": "1. Term:",
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ],
          "confidence": 0.997229814529419
        },
        {
          "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
          "bbox": [
            482.0,
            539.0,
            3023.0,
            585.0
          ],
          "confidence": 0.9943345785140991
        },
        {
          "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
          "bbox": [
            279.0,
            598.0,
            3027.0,
            640.0
          ],
          "confidence": 0.9962430596351624
        },
        {
          "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
          "bbox": [
            277.0,
            652.0,
            3025.0,
            696.0
          ],
          "confidence": 0.9910235404968262
        },
        {
          "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
          "bbox": [
            277.0,
            709.0,
            1626.0,
            749.0
          ],
          "confidence": 0.9774391651153564
        },
        {
          "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
          "bbox": [
            484.0,
            824.0,
            3025.0,
            861.0
          ],
          "confidence": 0.9801634550094604
        },
        {
          "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
          "bbox": [
            274.0,
            873.0,
            3031.0,
            926.0
          ],
          "confidence": 0.9838093519210815
        },
        {
          "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
          "bbox": [
            277.0,
            932.0,
            3031.0,
            976.0
          ],
          "confidence": 0.9960784912109375
        },
        {
          "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
          "bbox": [
            277.0,
            990.0,
            3030.0,
            1032.0
          ],
          "confidence": 0.9914847612380981
        },
        {
          "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
          "bbox": [
            275.0,
            1043.0,
            3029.0,
            1089.0
          ],
          "confidence": 0.9940744042396545
        },
        {
          "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
          "bbox": [
            279.0,
            1104.0,
            3027.0,
            1146.0
          ],
          "confidence": 0.9936762452125549
        },
        {
          "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
          "bbox": [
            277.0,
            1159.0,
            3027.0,
            1201.0
          ],
          "confidence": 0.9935197830200195
        },
        {
          "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
          "bbox": [
            275.0,
            1213.0,
            3029.0,
            1257.0
          ],
          "confidence": 0.9957082271575928
        },
        {
          "text": "on July 22, 2019.",
          "bbox": [
            275.0,
            1268.0,
            582.0,
            1316.0
          ],
          "confidence": 0.9980430603027344
        },
        {
          "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
          "bbox": [
            482.0,
            1383.0,
            3025.0,
            1427.0
          ],
          "confidence": 0.9859640002250671
        },
        {
          "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
          "bbox": [
            277.0,
            1436.0,
            3027.0,
            1482.0
          ],
          "confidence": 0.9967410564422607
        },
        {
          "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
          "bbox": [
            277.0,
            1493.0,
            3027.0,
            1537.0
          ],
          "confidence": 0.9919267892837524
        },
        {
          "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
          "bbox": [
            277.0,
            1548.0,
            3029.0,
            1593.0
          ],
          "confidence": 0.992956817150116
        },
        {
          "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
          "bbox": [
            277.0,
            1608.0,
            3029.0,
            1650.0
          ],
          "confidence": 0.9915570616722107
        },
        {
          "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
          "bbox": [
            277.0,
            1665.0,
            3029.0,
            1707.0
          ],
          "confidence": 0.991995632648468
        },
        {
          "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
          "bbox": [
            277.0,
            1720.0,
            3027.0,
            1760.0
          ],
          "confidence": 0.9876610636711121
        },
        {
          "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
          "bbox": [
            275.0,
            1773.0,
            2712.0,
            1818.0
          ],
          "confidence": 0.9991523027420044
        },
        {
          "text": "2. Engagement:",
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ],
          "confidence": 0.9804716110229492
        },
        {
          "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
          "bbox": [
            482.0,
            2005.0,
            3029.0,
            2047.0
          ],
          "confidence": 0.996250569820404
        },
        {
          "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
          "bbox": [
            279.0,
            2061.0,
            3027.0,
            2103.0
          ],
          "confidence": 0.9990272521972656
        },
        {
          "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
          "bbox": [
            279.0,
            2120.0,
            3025.0,
            2156.0
          ],
          "confidence": 0.9871711730957031
        },
        {
          "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
          "bbox": [
            275.0,
            2171.0,
            3031.0,
            2215.0
          ],
          "confidence": 0.9904016256332397
        },
        {
          "text": "MusclePharm, its Products, and the Licensed Products.",
          "bbox": [
            279.0,
            2229.0,
            1303.0,
            2266.0
          ],
          "confidence": 0.9956653714179993
        },
        {
          "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
          "bbox": [
            332.0,
            4435.0,
            1289.0,
            4477.0
          ],
          "confidence": 0.997590184211731
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "1. Term:",
          "page": 1,
          "bbox": [
            444.0,
            422.0,
            598.0,
            466.0
          ]
        },
        {
          "text": "2. Engagement:",
          "page": 1,
          "bbox": [
            444.0,
            1886.0,
            749.0,
            1935.0
          ]
        }
      ]
    }
  ]
}